KR20140097197A - 피리미딘-4-온 유도체 및 바이러스성 질환을 치료, 개선 또는 예방하는데 있어서의 이들의 용도 - Google Patents

Info

Publication number

KR20140097197A

KR20140097197A KR1020147013721A KR20147013721A KR20140097197A KR 20140097197 A KR20140097197 A KR 20140097197A KR 1020147013721 A KR1020147013721 A KR 1020147013721A KR 20147013721 A KR20147013721 A KR 20147013721A KR 20140097197 A KR20140097197 A KR 20140097197A

Authority

KR

South Korea

Prior art keywords

alkyl

cycloalkyl

compound

aryl

heterocyclyl

Prior art date

2011-10-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 230000003612 virological effect Effects 0.000 title claims abstract description 58
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 35
• 201000010099 disease Diseases 0.000 title claims abstract description 31
• 230000002265 prevention Effects 0.000 title claims 3
• DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical class O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 title description 2
• 150000001875 compounds Chemical class 0.000 claims abstract description 506
• 150000003839 salts Chemical class 0.000 claims abstract description 23
• 239000012453 solvate Substances 0.000 claims abstract description 14
• 229940002612 prodrug Drugs 0.000 claims abstract description 13
• 239000000651 prodrug Substances 0.000 claims abstract description 13
• 238000000034 method Methods 0.000 claims description 202
• 239000000203 mixture Substances 0.000 claims description 156
• 125000000217 alkyl group Chemical group 0.000 claims description 107
• 206010057190 Respiratory tract infections Diseases 0.000 claims description 41
• 206010022000 influenza Diseases 0.000 claims description 30
• 125000001424 substituent group Chemical group 0.000 claims description 28
• 125000000623 heterocyclic group Chemical group 0.000 claims description 23
• 125000003118 aryl group Chemical group 0.000 claims description 21
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 19
• 239000003446 ligand Substances 0.000 claims description 18
• 125000005842 heteroatom Chemical group 0.000 claims description 17
• 238000003556 assay Methods 0.000 claims description 14
• 229910052760 oxygen Inorganic materials 0.000 claims description 14
• 229910052717 sulfur Inorganic materials 0.000 claims description 14
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
• 125000003107 substituted aryl group Chemical group 0.000 claims description 12
• 229940123066 Polymerase inhibitor Drugs 0.000 claims description 11
• 125000001072 heteroaryl group Chemical group 0.000 claims description 11
• 239000002911 sialidase inhibitor Substances 0.000 claims description 11
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 10
• 229940123424 Neuraminidase inhibitor Drugs 0.000 claims description 10
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
• 239000003795 chemical substances by application Substances 0.000 claims description 9
• 239000001257 hydrogen Substances 0.000 claims description 9
• 229910052739 hydrogen Inorganic materials 0.000 claims description 9
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 9
• 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 8
• 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 8
• 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 8
• 125000002950 monocyclic group Chemical group 0.000 claims description 8
• 239000008194 pharmaceutical composition Substances 0.000 claims description 8
• 230000009467 reduction Effects 0.000 claims description 8
• 229910052736 halogen Inorganic materials 0.000 claims description 7
• 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims description 6
• 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 6
• 229910052799 carbon Inorganic materials 0.000 claims description 6
• 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims description 5
• 241000712891 Arenavirus Species 0.000 claims description 5
• 239000003888 alpha glucosidase inhibitor Substances 0.000 claims description 5
• 229940125400 channel inhibitor Drugs 0.000 claims description 5
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 5
• 241001529453 unidentified herpesvirus Species 0.000 claims description 5
• 241001430294 unidentified retrovirus Species 0.000 claims description 5
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 4
• 101100240521 Caenorhabditis elegans nhr-16 gene Proteins 0.000 claims description 4
• 241000711573 Coronaviridae Species 0.000 claims description 4
• 241000709664 Picornaviridae Species 0.000 claims description 4
• 239000003242 anti bacterial agent Substances 0.000 claims description 4
• 241000711950 Filoviridae Species 0.000 claims description 3
• 229940088710 antibiotic agent Drugs 0.000 claims description 3
• 125000002837 carbocyclic group Chemical group 0.000 claims description 3
• 150000002367 halogens Chemical class 0.000 claims description 3
• 101800004538 Bradykinin Proteins 0.000 claims description 2
• QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 2
• 102100035792 Kininogen-1 Human genes 0.000 claims description 2
• 239000000867 Lipoxygenase Inhibitor Substances 0.000 claims description 2
• OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 claims description 2
• 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
• 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
• QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 2
• 229930003827 cannabinoid Natural products 0.000 claims description 2
• 239000003557 cannabinoid Substances 0.000 claims description 2
• 238000010494 dissociation reaction Methods 0.000 claims description 2
• 230000005593 dissociations Effects 0.000 claims description 2
• 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
• 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 abstract description 2
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 195
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 177
• 239000000843 powder Substances 0.000 description 158
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 123
• 239000000243 solution Substances 0.000 description 107
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 70
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 68
• -1 subunits PA Proteins 0.000 description 52
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 51
• 238000003818 flash chromatography Methods 0.000 description 48
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
• 239000003112 inhibitor Substances 0.000 description 45
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
• 241000700605 Viruses Species 0.000 description 38
• 239000012044 organic layer Substances 0.000 description 38
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
• 238000001816 cooling Methods 0.000 description 36
• XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 35
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 35
• 235000019341 magnesium sulphate Nutrition 0.000 description 35
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
• 239000003814 drug Substances 0.000 description 28
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
• 210000004027 cell Anatomy 0.000 description 26
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
• 102000028391 RNA cap binding Human genes 0.000 description 24
• 108091000106 RNA cap binding Proteins 0.000 description 24
• 229940079593 drug Drugs 0.000 description 24
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
• 230000000840 anti-viral effect Effects 0.000 description 22
• 239000012230 colorless oil Substances 0.000 description 22
• 230000000694 effects Effects 0.000 description 22
• 102100031780 Endonuclease Human genes 0.000 description 21
• 108010042407 Endonucleases Proteins 0.000 description 21
• 239000002904 solvent Substances 0.000 description 21
• 239000000543 intermediate Substances 0.000 description 20
• 241000712461 unidentified influenza virus Species 0.000 description 20
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 18
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
• 239000003921 oil Substances 0.000 description 18
• 235000019198 oils Nutrition 0.000 description 18
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 17
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
• 239000007787 solid Substances 0.000 description 17
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 16
• 239000000872 buffer Substances 0.000 description 15
• 230000002401 inhibitory effect Effects 0.000 description 15
• 239000002244 precipitate Substances 0.000 description 15
• 230000004044 response Effects 0.000 description 15
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 13
• 229910000041 hydrogen chloride Inorganic materials 0.000 description 13
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 12
• 229910019142 PO4 Inorganic materials 0.000 description 12
• 239000003443 antiviral agent Substances 0.000 description 12
• 239000006260 foam Substances 0.000 description 12
• 235000021317 phosphate Nutrition 0.000 description 12
• 239000000523 sample Substances 0.000 description 12
• 239000012047 saturated solution Substances 0.000 description 12
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
• 108020004999 messenger RNA Proteins 0.000 description 11
• 239000010452 phosphate Substances 0.000 description 11
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 11
• 239000000741 silica gel Substances 0.000 description 11
• 229910002027 silica gel Inorganic materials 0.000 description 11
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
• 235000017557 sodium bicarbonate Nutrition 0.000 description 11
• 230000009385 viral infection Effects 0.000 description 11
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
• ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 10
• 238000006243 chemical reaction Methods 0.000 description 10
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
• YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 208000036142 Viral infection Diseases 0.000 description 9
• 230000008901 benefit Effects 0.000 description 9
• 230000000120 cytopathologic effect Effects 0.000 description 9
• 230000007246 mechanism Effects 0.000 description 9
• YSNXOQGDHGUKCZ-UHFFFAOYSA-N n-benzylhydroxylamine;hydron;chloride Chemical compound Cl.ONCC1=CC=CC=C1 YSNXOQGDHGUKCZ-UHFFFAOYSA-N 0.000 description 9
• 239000011780 sodium chloride Substances 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• 230000008685 targeting Effects 0.000 description 9
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 9
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 8
• 229940124639 Selective inhibitor Drugs 0.000 description 8
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
• 235000011054 acetic acid Nutrition 0.000 description 8
• 230000037396 body weight Effects 0.000 description 8
• 239000000706 filtrate Substances 0.000 description 8
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 230000002195 synergetic effect Effects 0.000 description 8
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 7
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 7
• 239000002253 acid Substances 0.000 description 7
• 230000009471 action Effects 0.000 description 7
• 231100000673 dose–response relationship Toxicity 0.000 description 7
• 230000006870 function Effects 0.000 description 7
• LVCDXCQFSONNDO-UHFFFAOYSA-N n-benzylhydroxylamine Chemical compound ONCC1=CC=CC=C1 LVCDXCQFSONNDO-UHFFFAOYSA-N 0.000 description 7
• 108090000623 proteins and genes Proteins 0.000 description 7
• 102000004169 proteins and genes Human genes 0.000 description 7
• 230000001850 reproductive effect Effects 0.000 description 7
• 238000003756 stirring Methods 0.000 description 7
• 230000002103 transcriptional effect Effects 0.000 description 7
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
• 235000019502 Orange oil Nutrition 0.000 description 6
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 6
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 6
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
• 150000001412 amines Chemical class 0.000 description 6
• 229910021529 ammonia Inorganic materials 0.000 description 6
• 239000012267 brine Substances 0.000 description 6
• 238000011088 calibration curve Methods 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
• 230000003834 intracellular effect Effects 0.000 description 6
• 239000011976 maleic acid Substances 0.000 description 6
• HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 6
• NUXCOKIYARRTDC-UHFFFAOYSA-N o-ethylhydroxylamine;hydron;chloride Chemical compound Cl.CCON NUXCOKIYARRTDC-UHFFFAOYSA-N 0.000 description 6
• 239000010502 orange oil Substances 0.000 description 6
• 229960003752 oseltamivir Drugs 0.000 description 6
• NENPYTRHICXVCS-YNEHKIRRSA-N oseltamivir acid Chemical compound CCC(CC)O[C@@H]1C=C(C(O)=O)C[C@H](N)[C@H]1NC(C)=O NENPYTRHICXVCS-YNEHKIRRSA-N 0.000 description 6
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
• ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 6
• 230000001932 seasonal effect Effects 0.000 description 6
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
• 239000011550 stock solution Substances 0.000 description 6
• 239000000758 substrate Substances 0.000 description 6
• HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 6
• NDMFETHQFUOIQX-UHFFFAOYSA-N 1-(3-chloropropyl)imidazolidin-2-one Chemical compound ClCCCN1CCNC1=O NDMFETHQFUOIQX-UHFFFAOYSA-N 0.000 description 5
• YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 5
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
• CNCJXSKAKGXNKJ-UHFFFAOYSA-N 5-phenylpyridine-2-carboxylic acid Chemical compound C1=NC(C(=O)O)=CC=C1C1=CC=CC=C1 CNCJXSKAKGXNKJ-UHFFFAOYSA-N 0.000 description 5
• 241000271566 Aves Species 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
• 239000007983 Tris buffer Substances 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
• 238000011161 development Methods 0.000 description 5
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 5
• 238000000338 in vitro Methods 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 208000015181 infectious disease Diseases 0.000 description 5
• YHOVYZINCVIRGK-UHFFFAOYSA-N methyl 4-aminopyridine-2-carboxylate Chemical compound COC(=O)C1=CC(N)=CC=N1 YHOVYZINCVIRGK-UHFFFAOYSA-N 0.000 description 5
• 239000004094 surface-active agent Substances 0.000 description 5
• WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 4
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
• VLWNCJPMUMKUMF-UHFFFAOYSA-N 4-(1-hydroxypropyl)benzene-1,2-diol Chemical compound CCC(O)C1=CC=C(O)C(O)=C1 VLWNCJPMUMKUMF-UHFFFAOYSA-N 0.000 description 4
• ACLFTMQROMOTLA-UHFFFAOYSA-N 5-pyrrolidin-1-ylpyridine-2-carboxylic acid Chemical compound C1=NC(C(=O)O)=CC=C1N1CCCC1 ACLFTMQROMOTLA-UHFFFAOYSA-N 0.000 description 4
• 229940123734 Endonuclease inhibitor Drugs 0.000 description 4
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
• 241000712431 Influenza A virus Species 0.000 description 4
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
• 108020005161 RNA Caps Proteins 0.000 description 4
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
• 206010064097 avian influenza Diseases 0.000 description 4
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical group NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
• 229910052794 bromium Inorganic materials 0.000 description 4
• XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 4
• 125000004432 carbon atom Chemical group C* 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 239000006185 dispersion Substances 0.000 description 4
• 229960001484 edetic acid Drugs 0.000 description 4
• MKJQYFVTEPGXIE-UHFFFAOYSA-N ethyl 2-aminothiophene-3-carboxylate Chemical compound CCOC(=O)C=1C=CSC=1N MKJQYFVTEPGXIE-UHFFFAOYSA-N 0.000 description 4
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
• 208000037797 influenza A Diseases 0.000 description 4
• 239000010410 layer Substances 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 229910052757 nitrogen Inorganic materials 0.000 description 4
• KKVUFSINQFSJNK-UHFFFAOYSA-N o-tert-butylhydroxylamine Chemical compound CC(C)(C)ON KKVUFSINQFSJNK-UHFFFAOYSA-N 0.000 description 4
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
• 239000012146 running buffer Substances 0.000 description 4
• 239000012266 salt solution Substances 0.000 description 4
• 239000007921 spray Substances 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
• UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 3
• LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
• UZUZFQGQSFJGER-UHFFFAOYSA-N 1-phenyl-n-phenylmethoxymethanamine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1CNOCC1=CC=CC=C1 UZUZFQGQSFJGER-UHFFFAOYSA-N 0.000 description 3
• LANXHIADXJLQQS-UHFFFAOYSA-N 2-amino-5-methyl-3h-thieno[2,3-d]pyrimidin-4-one Chemical compound N1=C(N)NC(=O)C2=C1SC=C2C LANXHIADXJLQQS-UHFFFAOYSA-N 0.000 description 3
• JUAOCWQIOWLYJV-UHFFFAOYSA-N 4-piperidin-1-ylpyridine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1=NC(C(=O)O)=CC(N2CCCCC2)=C1 JUAOCWQIOWLYJV-UHFFFAOYSA-N 0.000 description 3
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 3
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 102000005348 Neuraminidase Human genes 0.000 description 3
• 108010006232 Neuraminidase Proteins 0.000 description 3
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 3
• 125000003342 alkenyl group Chemical group 0.000 description 3
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 3
• 229960003805 amantadine Drugs 0.000 description 3
• 239000000908 ammonium hydroxide Substances 0.000 description 3
• 239000012298 atmosphere Substances 0.000 description 3
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
• 230000003197 catalytic effect Effects 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 230000003013 cytotoxicity Effects 0.000 description 3
• 231100000135 cytotoxicity Toxicity 0.000 description 3
• YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 3
• 239000003085 diluting agent Substances 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 3
• 150000002431 hydrogen Chemical class 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
• MTINZHXYVLZMMH-UHFFFAOYSA-N n-[(2-methylpropan-2-yl)oxy]isoquinoline-3-carboxamide Chemical compound C1=CC=C2C=NC(C(=O)NOC(C)(C)C)=CC2=C1 MTINZHXYVLZMMH-UHFFFAOYSA-N 0.000 description 3
• XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical compound NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 description 3
• ZBDXGNXNXXPKJI-UHFFFAOYSA-N o-tert-butylhydroxylamine;hydrochloride Chemical compound Cl.CC(C)(C)ON ZBDXGNXNXXPKJI-UHFFFAOYSA-N 0.000 description 3
• 239000003960 organic solvent Substances 0.000 description 3
• 238000007911 parenteral administration Methods 0.000 description 3
• 229910000027 potassium carbonate Inorganic materials 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 239000011541 reaction mixture Substances 0.000 description 3
• 229960000329 ribavirin Drugs 0.000 description 3
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 3
• 229960000888 rimantadine Drugs 0.000 description 3
• 229920006395 saturated elastomer Polymers 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 210000002784 stomach Anatomy 0.000 description 3
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• GZMJRPMBVICCFL-UHFFFAOYSA-N (3,5-dichlorophenyl)methanesulfonyl chloride Chemical compound ClC1=CC(Cl)=CC(CS(Cl)(=O)=O)=C1 GZMJRPMBVICCFL-UHFFFAOYSA-N 0.000 description 2
• WDGWHKRJEBENCE-UHFFFAOYSA-N (3-carbamoylphenyl)boronic acid Chemical compound NC(=O)C1=CC=CC(B(O)O)=C1 WDGWHKRJEBENCE-UHFFFAOYSA-N 0.000 description 2
• LXTGNVLBPVVMSL-UHFFFAOYSA-N (3-chlorophenyl)methanesulfonyl chloride Chemical compound ClC1=CC=CC(CS(Cl)(=O)=O)=C1 LXTGNVLBPVVMSL-UHFFFAOYSA-N 0.000 description 2
• QKGIPEQAFOXGSI-UHFFFAOYSA-N (3-fluorophenyl)methanesulfonyl chloride Chemical compound FC1=CC=CC(CS(Cl)(=O)=O)=C1 QKGIPEQAFOXGSI-UHFFFAOYSA-N 0.000 description 2
• QSWLFBMVIGQONC-UHFFFAOYSA-N (3-propan-2-ylphenyl)boronic acid Chemical compound CC(C)C1=CC=CC(B(O)O)=C1 QSWLFBMVIGQONC-UHFFFAOYSA-N 0.000 description 2
• LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 2
• WFWKNGZODAOLEO-UHFFFAOYSA-N 1-(4-Methoxyphenyl)-2-propanone Chemical compound COC1=CC=C(CC(C)=O)C=C1 WFWKNGZODAOLEO-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
• BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 2
• MNZUXCCLJPAXEP-UHFFFAOYSA-N 2-methyl-6-phenyl-3h-thieno[2,3-d]pyrimidin-4-one Chemical compound C=1C=2C(=O)NC(C)=NC=2SC=1C1=CC=CC=C1 MNZUXCCLJPAXEP-UHFFFAOYSA-N 0.000 description 2
• GKJFJQTVFQSAIZ-UHFFFAOYSA-N 4-[benzyl(methyl)amino]pyridine-2-carboxylic acid Chemical compound C=1C=NC(C(O)=O)=CC=1N(C)CC1=CC=CC=C1 GKJFJQTVFQSAIZ-UHFFFAOYSA-N 0.000 description 2
• JRZBTJVSAANBEV-UHFFFAOYSA-N 4-aminopyridine-2-carboxylic acid Chemical compound NC1=CC=NC(C(O)=O)=C1 JRZBTJVSAANBEV-UHFFFAOYSA-N 0.000 description 2
• ILRFQOQPKZAZGM-UHFFFAOYSA-N 4-bromo-n-[(2-methylpropan-2-yl)oxy]pyridine-2-carboxamide Chemical compound CC(C)(C)ONC(=O)C1=CC(Br)=CC=N1 ILRFQOQPKZAZGM-UHFFFAOYSA-N 0.000 description 2
• DDXBJYCJBRZTBL-UHFFFAOYSA-N 4-bromo-n-[(4-fluorophenyl)methyl]-n-(oxan-2-yloxy)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN(C(=O)C=1N=CC=C(Br)C=1)OC1OCCCC1 DDXBJYCJBRZTBL-UHFFFAOYSA-N 0.000 description 2
• 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 2
• BYBSZAWOQUXYBY-UHFFFAOYSA-N 4-morpholin-4-ylpyridine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1=NC(C(=O)O)=CC(N2CCOCC2)=C1 BYBSZAWOQUXYBY-UHFFFAOYSA-N 0.000 description 2
• VSKRUAKMKGOMBG-UHFFFAOYSA-N 4-phenylpyridine-2-carboxylic acid Chemical compound C1=NC(C(=O)O)=CC(C=2C=CC=CC=2)=C1 VSKRUAKMKGOMBG-UHFFFAOYSA-N 0.000 description 2
• VSOBNHCLIYWKKP-UHFFFAOYSA-N 5-(3-propan-2-ylphenyl)pyridine-2-carboxylic acid Chemical compound CC(C)C1=CC=CC(C=2C=NC(=CC=2)C(O)=O)=C1 VSOBNHCLIYWKKP-UHFFFAOYSA-N 0.000 description 2
• XCOUHSHXXPLMMI-UHFFFAOYSA-N 5-piperidin-1-ylpyridine-2-carboxylic acid Chemical compound C1=NC(C(=O)O)=CC=C1N1CCCCC1 XCOUHSHXXPLMMI-UHFFFAOYSA-N 0.000 description 2
• DPDUKAKBKHZBQZ-UHFFFAOYSA-N 6-methyl-n-phenylmethoxypyridine-2-carboxamide Chemical compound CC1=CC=CC(C(=O)NOCC=2C=CC=CC=2)=N1 DPDUKAKBKHZBQZ-UHFFFAOYSA-N 0.000 description 2
• LTUUGSGSUZRPRV-UHFFFAOYSA-N 6-methylpyridine-2-carboxylic acid Chemical compound CC1=CC=CC(C(O)=O)=N1 LTUUGSGSUZRPRV-UHFFFAOYSA-N 0.000 description 2
• OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 description 2
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• 229940124638 COX inhibitor Drugs 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
• 241000710831 Flavivirus Species 0.000 description 2
• SIXHCCPAJIVTOY-UHFFFAOYSA-N Flutimide Natural products CC(C)CC1=NC(=CC(C)C)C(=O)N(O)C1=O SIXHCCPAJIVTOY-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• 239000007995 HEPES buffer Substances 0.000 description 2
• 206010019799 Hepatitis viral Diseases 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 2
• 208000002979 Influenza in Birds Diseases 0.000 description 2
• 108090000862 Ion Channels Proteins 0.000 description 2
• 102000004310 Ion Channels Human genes 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
• WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 2
• 241001631646 Papillomaviridae Species 0.000 description 2
• 206010034133 Pathogen resistance Diseases 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• WIGCBGFBBRJTLS-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]methanesulfonyl chloride Chemical compound FC(F)(F)C1=CC=CC(CS(Cl)(=O)=O)=C1 WIGCBGFBBRJTLS-UHFFFAOYSA-N 0.000 description 2
• ITLHXEGAYQFOHJ-UHFFFAOYSA-N [diazo(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(=[N+]=[N-])C1=CC=CC=C1 ITLHXEGAYQFOHJ-UHFFFAOYSA-N 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 125000003545 alkoxy group Chemical group 0.000 description 2
• 125000000304 alkynyl group Chemical group 0.000 description 2
• 229940024606 amino acid Drugs 0.000 description 2
• 239000012491 analyte Substances 0.000 description 2
• 239000004599 antimicrobial Substances 0.000 description 2
• 125000003710 aryl alkyl group Chemical group 0.000 description 2
• 239000012131 assay buffer Substances 0.000 description 2
• 244000309743 astrovirus Species 0.000 description 2
• HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
• AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 2
• MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 150000001721 carbon Chemical group 0.000 description 2
• 229910002091 carbon monoxide Inorganic materials 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• 229910052801 chlorine Inorganic materials 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 235000015165 citric acid Nutrition 0.000 description 2
• 229940110456 cocoa butter Drugs 0.000 description 2
• 235000019868 cocoa butter Nutrition 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
• USVZFSNDGFNNJT-UHFFFAOYSA-N cyclopenta-1,4-dien-1-yl(diphenyl)phosphane (2,3-dichlorocyclopenta-1,4-dien-1-yl)-diphenylphosphane iron(2+) Chemical compound [Fe++].c1cc[c-](c1)P(c1ccccc1)c1ccccc1.Clc1c(cc[c-]1Cl)P(c1ccccc1)c1ccccc1 USVZFSNDGFNNJT-UHFFFAOYSA-N 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 2
• 229940043264 dodecyl sulfate Drugs 0.000 description 2
• XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
• MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 2
• PSDSXQUMBODBRC-UHFFFAOYSA-N ethyl 5-bromo-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate Chemical compound CCOC(=O)C=1C(C)=C(Br)SC=1NC(=O)OC(C)(C)C PSDSXQUMBODBRC-UHFFFAOYSA-N 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 229910052731 fluorine Inorganic materials 0.000 description 2
• QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
• SIXHCCPAJIVTOY-UITAMQMPSA-N flutimide Chemical compound CC(C)CC1=N\C(=C/C(C)C)C(=O)N(O)C1=O SIXHCCPAJIVTOY-UITAMQMPSA-N 0.000 description 2
• 239000012634 fragment Substances 0.000 description 2
• 238000009650 gentamicin protection assay Methods 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 229910052740 iodine Inorganic materials 0.000 description 2
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
• 229940126181 ion channel inhibitor Drugs 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
• QKYRXLPXSJZIQM-UHFFFAOYSA-N methyl 2-amino-5-phenylthiophene-3-carboxylate Chemical compound S1C(N)=C(C(=O)OC)C=C1C1=CC=CC=C1 QKYRXLPXSJZIQM-UHFFFAOYSA-N 0.000 description 2
• ZFLNHISOGSWDDI-UHFFFAOYSA-N methyl 4-azidopyridine-2-carboxylate Chemical compound COC(=O)C1=CC(N=[N+]=[N-])=CC=N1 ZFLNHISOGSWDDI-UHFFFAOYSA-N 0.000 description 2
• TVGVKAPPALAZQW-UHFFFAOYSA-N methyl 4-benzamidopyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(NC(=O)C=2C=CC=CC=2)=C1 TVGVKAPPALAZQW-UHFFFAOYSA-N 0.000 description 2
• VTENWIPSWAMPKI-UHFFFAOYSA-N methyl 4-chloropyridine-2-carboxylate Chemical compound COC(=O)C1=CC(Cl)=CC=N1 VTENWIPSWAMPKI-UHFFFAOYSA-N 0.000 description 2
• MCROFRIFKOWIKP-UHFFFAOYSA-N methyl 5-(3-propan-2-ylphenyl)pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC=C1C1=CC=CC(C(C)C)=C1 MCROFRIFKOWIKP-UHFFFAOYSA-N 0.000 description 2
• CPWMCAMLRLHDAT-UHFFFAOYSA-N methyl 5-bromo-3-(bromomethyl)pyridine-2-carboxylate Chemical compound COC(=O)C1=NC=C(Br)C=C1CBr CPWMCAMLRLHDAT-UHFFFAOYSA-N 0.000 description 2
• SNNWFCONBAXIIY-UHFFFAOYSA-N methyl 5-bromo-3-[[(2-methylpropan-2-yl)oxyamino]methyl]pyridine-2-carboxylate Chemical compound COC(=O)C1=NC=C(Br)C=C1CNOC(C)(C)C SNNWFCONBAXIIY-UHFFFAOYSA-N 0.000 description 2
• JEURNBCYNWNADN-UHFFFAOYSA-N methyl 5-bromopyridine-2-carboxylate Chemical compound COC(=O)C1=CC=C(Br)C=N1 JEURNBCYNWNADN-UHFFFAOYSA-N 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
• FTEKLZONWYPLCZ-UHFFFAOYSA-N n-(3-phenylpropyl)hydroxylamine Chemical compound ONCCCC1=CC=CC=C1 FTEKLZONWYPLCZ-UHFFFAOYSA-N 0.000 description 2
• XGMUBPKIFGVRBN-UHFFFAOYSA-N n-(oxan-2-yloxy)-3-(sulfonylamino)pyridine-2-carboxamide Chemical compound N=1C=CC=C(N=S(=O)=O)C=1C(=O)NOC1CCCCO1 XGMUBPKIFGVRBN-UHFFFAOYSA-N 0.000 description 2
• WZQLCXHUBHSTLN-UHFFFAOYSA-N n-(oxan-2-yloxy)-5-phenylpyridine-2-carboxamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=NC=1C(=O)NOC1CCCCO1 WZQLCXHUBHSTLN-UHFFFAOYSA-N 0.000 description 2
• OVUIUUQZIUFRFY-UHFFFAOYSA-N n-[(2-methylpropan-2-yl)oxy]-n-(2-phenylethyl)isoquinoline-3-carboxamide Chemical compound C=1C2=CC=CC=C2C=NC=1C(=O)N(OC(C)(C)C)CCC1=CC=CC=C1 OVUIUUQZIUFRFY-UHFFFAOYSA-N 0.000 description 2
• WGPVCUCTCUKFOZ-UHFFFAOYSA-N n-benzyl-4-bromo-n-(oxan-2-yloxy)pyridine-2-carboxamide Chemical compound BrC1=CC=NC(C(=O)N(CC=2C=CC=CC=2)OC2OCCCC2)=C1 WGPVCUCTCUKFOZ-UHFFFAOYSA-N 0.000 description 2
• DNPWNITZGAITLE-UHFFFAOYSA-N n-ethoxy-5-phenylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NOCC)=CC=C1C1=CC=CC=C1 DNPWNITZGAITLE-UHFFFAOYSA-N 0.000 description 2
• DMYHBSUUUAJWBZ-UHFFFAOYSA-N n-ethoxy-6-methylpyridine-2-carboxamide Chemical compound CCONC(=O)C1=CC=CC(C)=N1 DMYHBSUUUAJWBZ-UHFFFAOYSA-N 0.000 description 2
• YRNWHNCFCNTTPH-UHFFFAOYSA-N n-ethoxy-n-methyl-5-(3-propan-2-ylphenyl)pyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(C)OCC)=CC=C1C1=CC=CC(C(C)C)=C1 YRNWHNCFCNTTPH-UHFFFAOYSA-N 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 150000003833 nucleoside derivatives Chemical class 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
• 229910052763 palladium Inorganic materials 0.000 description 2
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
• HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
• OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 2
• 239000008363 phosphate buffer Substances 0.000 description 2
• SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
• 239000003380 propellant Substances 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 239000012723 sample buffer Substances 0.000 description 2
• DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 235000015424 sodium Nutrition 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 229910000029 sodium carbonate Inorganic materials 0.000 description 2
• 229940045902 sodium stearyl fumarate Drugs 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 230000001954 sterilising effect Effects 0.000 description 2
• 238000004659 sterilization and disinfection Methods 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 201000010740 swine influenza Diseases 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 229940095064 tartrate Drugs 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
• 235000010215 titanium dioxide Nutrition 0.000 description 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 230000006490 viral transcription Effects 0.000 description 2
• 229960001028 zanamivir Drugs 0.000 description 2
• ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 2
• LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
• CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
• UGTSPJDUUYLVMM-UHFFFAOYSA-N (2,3-dichlorophenyl)methanesulfonyl chloride Chemical compound ClC1=CC=CC(CS(Cl)(=O)=O)=C1Cl UGTSPJDUUYLVMM-UHFFFAOYSA-N 0.000 description 1
• FZPDXWVJKNHDOQ-UHFFFAOYSA-N (2,4-dichlorophenyl) ethyl carbonate Chemical compound CCOC(=O)OC1=CC=C(Cl)C=C1Cl FZPDXWVJKNHDOQ-UHFFFAOYSA-N 0.000 description 1
• QQLRSCZSKQTFGY-UHFFFAOYSA-N (2,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C=C1F QQLRSCZSKQTFGY-UHFFFAOYSA-N 0.000 description 1
• LCCZTROJRJFXNV-UHFFFAOYSA-N (2,6-difluoropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC=C(F)N=C1F LCCZTROJRJFXNV-UHFFFAOYSA-N 0.000 description 1
• ZXGCWGYBIXCFMP-UHFFFAOYSA-N (2-chloro-3-fluoropyridin-4-yl)boronic acid Chemical compound OB(O)C1=CC=NC(Cl)=C1F ZXGCWGYBIXCFMP-UHFFFAOYSA-N 0.000 description 1
• YNZXUVCJPQNYHR-UHFFFAOYSA-N (2-chloro-5-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC(C#N)=CC=C1Cl YNZXUVCJPQNYHR-UHFFFAOYSA-N 0.000 description 1
• RRCMGJCFMJBHQC-UHFFFAOYSA-N (2-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1Cl RRCMGJCFMJBHQC-UHFFFAOYSA-N 0.000 description 1
• CHPZYFXSICSCNY-UHFFFAOYSA-N (2-chlorophenyl)methanesulfonyl chloride Chemical compound ClC1=CC=CC=C1CS(Cl)(=O)=O CHPZYFXSICSCNY-UHFFFAOYSA-N 0.000 description 1
• QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
• CJDWSUDXKHLMCY-UHFFFAOYSA-N (2-fluorophenyl)methanesulfonyl chloride Chemical compound FC1=CC=CC=C1CS(Cl)(=O)=O CJDWSUDXKHLMCY-UHFFFAOYSA-N 0.000 description 1
• HNVIQLPOGUDBSU-OLQVQODUSA-N (2s,6r)-2,6-dimethylmorpholine Chemical compound C[C@H]1CNC[C@@H](C)O1 HNVIQLPOGUDBSU-OLQVQODUSA-N 0.000 description 1
• JKIGHOARKAIPJI-UHFFFAOYSA-N (3,4-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(Cl)=C1 JKIGHOARKAIPJI-UHFFFAOYSA-N 0.000 description 1
• DRYGYFAFCNDLEJ-UHFFFAOYSA-N (3,4-dichlorophenyl)methanesulfonyl chloride Chemical compound ClC1=CC=C(CS(Cl)(=O)=O)C=C1Cl DRYGYFAFCNDLEJ-UHFFFAOYSA-N 0.000 description 1
• VCGKEAIINMDLMC-UHFFFAOYSA-N (3-bromophenyl)methanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC(Br)=C1 VCGKEAIINMDLMC-UHFFFAOYSA-N 0.000 description 1
• ZSMAOKOKSOKHOU-UHFFFAOYSA-N (3-chloro-2,6-difluorophenyl)boronic acid Chemical compound OB(O)C1=C(F)C=CC(Cl)=C1F ZSMAOKOKSOKHOU-UHFFFAOYSA-N 0.000 description 1
• SUYRGLRWMPEARP-UHFFFAOYSA-N (3-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1F SUYRGLRWMPEARP-UHFFFAOYSA-N 0.000 description 1
• OLKIYJDSLMKNLC-UHFFFAOYSA-N (3-cyano-4-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(C#N)=C1 OLKIYJDSLMKNLC-UHFFFAOYSA-N 0.000 description 1
• XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 1
• KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 1
• BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
• GNRHNKBJNUVWFZ-UHFFFAOYSA-N (4-carbamoylphenyl)boronic acid Chemical compound NC(=O)C1=CC=C(B(O)O)C=C1 GNRHNKBJNUVWFZ-UHFFFAOYSA-N 0.000 description 1
• YBNDRTRLXPEWKQ-UHFFFAOYSA-N (4-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1F YBNDRTRLXPEWKQ-UHFFFAOYSA-N 0.000 description 1
• CMJQIHGBUKZEHP-UHFFFAOYSA-N (4-chloro-3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(F)=C1 CMJQIHGBUKZEHP-UHFFFAOYSA-N 0.000 description 1
• XMMHXKOVZNBHSA-UHFFFAOYSA-N (4-chloro-3-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(O)=C1 XMMHXKOVZNBHSA-UHFFFAOYSA-N 0.000 description 1
• DZNNRXURZJLARZ-UHFFFAOYSA-N (4-chloro-3-methoxyphenyl)boronic acid Chemical compound COC1=CC(B(O)O)=CC=C1Cl DZNNRXURZJLARZ-UHFFFAOYSA-N 0.000 description 1
• UZDPQDBLCJDUAX-UHFFFAOYSA-N (4-chloro-3-methylphenyl)boronic acid Chemical compound CC1=CC(B(O)O)=CC=C1Cl UZDPQDBLCJDUAX-UHFFFAOYSA-N 0.000 description 1
• CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
• DBJRPJSDYFDWPV-UHFFFAOYSA-N (4-chlorophenyl)methanesulfonyl chloride Chemical compound ClC1=CC=C(CS(Cl)(=O)=O)C=C1 DBJRPJSDYFDWPV-UHFFFAOYSA-N 0.000 description 1
• UUQGWVIRPCRTSA-UHFFFAOYSA-N (4-fluorophenyl)methanesulfonyl chloride Chemical compound FC1=CC=C(CS(Cl)(=O)=O)C=C1 UUQGWVIRPCRTSA-UHFFFAOYSA-N 0.000 description 1
• ITCSMTHUTFTXLE-UHFFFAOYSA-N (5-cyano-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC(C#N)=CC=C1F ITCSMTHUTFTXLE-UHFFFAOYSA-N 0.000 description 1
• WPAPNCXMYWRTTL-UHFFFAOYSA-N (6-chloropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)N=C1 WPAPNCXMYWRTTL-UHFFFAOYSA-N 0.000 description 1
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
• YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
• KPKNTUUIEVXMOH-UHFFFAOYSA-N 1,4-dioxa-8-azaspiro[4.5]decane Chemical compound O1CCOC11CCNCC1 KPKNTUUIEVXMOH-UHFFFAOYSA-N 0.000 description 1
• GJCJBLJHXIRPCX-UHFFFAOYSA-N 1-(4-fluorophenyl)-n-(oxan-2-yloxy)methanamine Chemical compound C1=CC(F)=CC=C1CNOC1OCCCC1 GJCJBLJHXIRPCX-UHFFFAOYSA-N 0.000 description 1
• NOXKUHSBIXPZBJ-UHFFFAOYSA-N 1-(4-methylphenyl)propan-2-one Chemical compound CC(=O)CC1=CC=C(C)C=C1 NOXKUHSBIXPZBJ-UHFFFAOYSA-N 0.000 description 1
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
• JPHQCDCEBDRIOL-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]propan-2-one Chemical compound CC(=O)CC1=CC=CC(C(F)(F)F)=C1 JPHQCDCEBDRIOL-UHFFFAOYSA-N 0.000 description 1
• WMMHWBVAEMEASZ-UHFFFAOYSA-N 1-[4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-n,n-dimethylmethanamine Chemical compound CN(C)CC1=CC=C(F)C(B2OC(C)(C)C(C)(C)O2)=C1 WMMHWBVAEMEASZ-UHFFFAOYSA-N 0.000 description 1
• SGIBOXBBPQRZDM-UHFFFAOYSA-N 1-benzylpiperidine-4-carbaldehyde Chemical compound C1CC(C=O)CCN1CC1=CC=CC=C1 SGIBOXBBPQRZDM-UHFFFAOYSA-N 0.000 description 1
• OUFKWUVRLBXOOG-UHFFFAOYSA-N 1-methyl-3,4-dihydro-2h-quinoline-6-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C2N(C)CCCC2=C1 OUFKWUVRLBXOOG-UHFFFAOYSA-N 0.000 description 1
• SQMVRFXDBRYXFQ-UHFFFAOYSA-N 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2h-pyridine Chemical compound C1N(C)CCC(B2OC(C)(C)C(C)(C)O2)=C1 SQMVRFXDBRYXFQ-UHFFFAOYSA-N 0.000 description 1
• WUUIYHZKEXDJKH-UHFFFAOYSA-N 1-phenyl-n-phenylmethoxymethanamine Chemical compound C=1C=CC=CC=1CNOCC1=CC=CC=C1 WUUIYHZKEXDJKH-UHFFFAOYSA-N 0.000 description 1
• HKVMSCXHSSBGRU-UHFFFAOYSA-N 1-pyrazin-2-ylpropan-2-one Chemical compound CC(=O)CC1=CN=CC=N1 HKVMSCXHSSBGRU-UHFFFAOYSA-N 0.000 description 1
• WPDJRDYNRNXPBX-UHFFFAOYSA-N 1-pyridin-3-ylpropan-2-one Chemical compound CC(=O)CC1=CC=CN=C1 WPDJRDYNRNXPBX-UHFFFAOYSA-N 0.000 description 1
• ILRVKOYYFFNXDB-UHFFFAOYSA-N 1-pyridin-4-ylpropan-2-one Chemical compound CC(=O)CC1=CC=NC=C1 ILRVKOYYFFNXDB-UHFFFAOYSA-N 0.000 description 1
• JCHWHOHZZYWUMP-UHFFFAOYSA-N 2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C(CC1)=CCC21OCCO2 JCHWHOHZZYWUMP-UHFFFAOYSA-N 0.000 description 1
• OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
• QNZFUMVTUFOLRT-UHFFFAOYSA-N 2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CCCCC1 QNZFUMVTUFOLRT-UHFFFAOYSA-N 0.000 description 1
• UYBMLDXQOFMMED-UHFFFAOYSA-N 2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-oxopyrrolidin-1-yl]acetic acid Chemical compound CC(C)(C)OC(=O)NC1CCN(CC(O)=O)C1=O UYBMLDXQOFMMED-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• VKDNLJXTQMTYEH-UHFFFAOYSA-N 2-amino-6-benzyl-3h-thieno[2,3-d]pyrimidin-4-one Chemical compound C=1C=2C(=O)NC(N)=NC=2SC=1CC1=CC=CC=C1 VKDNLJXTQMTYEH-UHFFFAOYSA-N 0.000 description 1
• CPVGQHGZVLAWBZ-UHFFFAOYSA-N 2-amino-6-phenyl-3h-thieno[2,3-d]pyrimidin-4-one Chemical compound C=1C=2C(=O)NC(N)=NC=2SC=1C1=CC=CC=C1 CPVGQHGZVLAWBZ-UHFFFAOYSA-N 0.000 description 1
• UXUZARPLRQRNNX-DXTOWSMRSA-N 2-amino-9-[(2r,3r,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1F UXUZARPLRQRNNX-DXTOWSMRSA-N 0.000 description 1
• NDOPHXWIAZIXPR-UHFFFAOYSA-N 2-bromobenzaldehyde Chemical compound BrC1=CC=CC=C1C=O NDOPHXWIAZIXPR-UHFFFAOYSA-N 0.000 description 1
• IIKVAWLYHHZRGV-UHFFFAOYSA-N 2-carbazol-9-ylethanol Chemical compound C1=CC=C2N(CCO)C3=CC=CC=C3C2=C1 IIKVAWLYHHZRGV-UHFFFAOYSA-N 0.000 description 1
• ZSNNELPPGKIDBW-UHFFFAOYSA-N 2-nitro-5-phenoxybenzoic acid Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(OC=2C=CC=CC=2)=C1 ZSNNELPPGKIDBW-UHFFFAOYSA-N 0.000 description 1
• LEHHIPIDKQVNEV-UHFFFAOYSA-N 3,3-difluoropiperidine;hydrochloride Chemical compound Cl.FC1(F)CCCNC1 LEHHIPIDKQVNEV-UHFFFAOYSA-N 0.000 description 1
• YYVPZQADFREIFR-UHFFFAOYSA-N 3,3-difluoropyrrolidine;hydrochloride Chemical compound [Cl-].FC1(F)CC[NH2+]C1 YYVPZQADFREIFR-UHFFFAOYSA-N 0.000 description 1
• NGNBLHNWFBBXFD-UHFFFAOYSA-N 3-(2-amino-5-methyl-4-oxo-3h-thieno[2,3-d]pyrimidin-6-yl)benzonitrile Chemical compound S1C=2N=C(N)NC(=O)C=2C(C)=C1C1=CC=CC(C#N)=C1 NGNBLHNWFBBXFD-UHFFFAOYSA-N 0.000 description 1
• GAMNINPBAOTMLA-UHFFFAOYSA-N 3-(3-chlorophenyl)propanal Chemical compound ClC1=CC=CC(CCC=O)=C1 GAMNINPBAOTMLA-UHFFFAOYSA-N 0.000 description 1
• JSHLMMUXJIDENZ-UHFFFAOYSA-N 3-(4-methylpiperazin-1-ium-1-yl)propanoate Chemical compound CN1CCN(CCC(O)=O)CC1 JSHLMMUXJIDENZ-UHFFFAOYSA-N 0.000 description 1
• DEYBKWDBHSNOKP-UHFFFAOYSA-N 3-(sulfonylamino)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=CC=C1N=S(=O)=O DEYBKWDBHSNOKP-UHFFFAOYSA-N 0.000 description 1
• GBKIYRAAWIQLAE-UHFFFAOYSA-N 3-bromo-6-[(2-methylpropan-2-yl)oxy]-5h-pyrrolo[3,4-b]pyridin-7-one Chemical compound BrC1=CN=C2C(=O)N(OC(C)(C)C)CC2=C1 GBKIYRAAWIQLAE-UHFFFAOYSA-N 0.000 description 1
• CEKLEAFATYDPDK-UHFFFAOYSA-N 3-bromo-6-hydroxy-5,7-dihydropyrrolo[3,4-b]pyridine Chemical compound BrC1=CN=C2CN(O)CC2=C1 CEKLEAFATYDPDK-UHFFFAOYSA-N 0.000 description 1
• SUISZCALMBHJQX-UHFFFAOYSA-N 3-bromobenzaldehyde Chemical compound BrC1=CC=CC(C=O)=C1 SUISZCALMBHJQX-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
• ALKYHXVLJMQRLQ-UHFFFAOYSA-M 3-carboxynaphthalen-2-olate Chemical compound C1=CC=C2C=C(C([O-])=O)C(O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-M 0.000 description 1
• 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
• 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
• XRRGMEXYNJFRAU-UHFFFAOYSA-N 3-methylthieno[2,3-d]pyrimidin-4-one Chemical compound O=C1N(C)C=NC2=C1C=CS2 XRRGMEXYNJFRAU-UHFFFAOYSA-N 0.000 description 1
• JAICGBJIBWDEIZ-UHFFFAOYSA-N 3-phenylmethoxybenzaldehyde Chemical compound O=CC1=CC=CC(OCC=2C=CC=CC=2)=C1 JAICGBJIBWDEIZ-UHFFFAOYSA-N 0.000 description 1
• 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
• OABUKBBBSMNNPM-UHFFFAOYSA-N 4,4-difluoropiperidin-1-ium;chloride Chemical compound Cl.FC1(F)CCNCC1 OABUKBBBSMNNPM-UHFFFAOYSA-N 0.000 description 1
• NHWRHEOCEWDYPJ-UHFFFAOYSA-N 4-(4-chlorophenyl)butan-2-one Chemical compound CC(=O)CCC1=CC=C(Cl)C=C1 NHWRHEOCEWDYPJ-UHFFFAOYSA-N 0.000 description 1
• VIAUFQXMPKNNPH-UHFFFAOYSA-N 4-(4-methylpiperazin-1-yl)butanoic acid;hydrochloride Chemical compound Cl.CN1CCN(CCCC(O)=O)CC1 VIAUFQXMPKNNPH-UHFFFAOYSA-N 0.000 description 1
• YUZXOZBRQUSVDI-UHFFFAOYSA-N 4-(benzenesulfonamido)-n-benzyl-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(NS(=O)(=O)C=2C=CC=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 YUZXOZBRQUSVDI-UHFFFAOYSA-N 0.000 description 1
• WMBQPOPLWVATCH-UHFFFAOYSA-N 4-(benzhydrylsulfonylamino)-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 WMBQPOPLWVATCH-UHFFFAOYSA-N 0.000 description 1
• CMHBMHVIZMDHQA-UHFFFAOYSA-N 4-(benzylamino)-n-[(2-methylpropan-2-yl)oxy]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)NOC(C)(C)C)=CC(NCC=2C=CC=CC=2)=C1 CMHBMHVIZMDHQA-UHFFFAOYSA-N 0.000 description 1
• LURIITKIOKXKEM-UHFFFAOYSA-N 4-(benzylamino)-n-hydroxypyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(NCC=2C=CC=CC=2)=C1 LURIITKIOKXKEM-UHFFFAOYSA-N 0.000 description 1
• PKQMEFKWJABEPE-UHFFFAOYSA-N 4-(benzylsulfonylamino)-n-hydroxypyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=CC=CC=2)=C1 PKQMEFKWJABEPE-UHFFFAOYSA-N 0.000 description 1
• BKVMQXBTZSNEAE-UHFFFAOYSA-N 4-[(2,3-dichlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C(=C(Cl)C=CC=2)Cl)=C1 BKVMQXBTZSNEAE-UHFFFAOYSA-N 0.000 description 1
• QFAASWLNYWBSSG-UHFFFAOYSA-N 4-[(2-chlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C(=CC=CC=2)Cl)=C1 QFAASWLNYWBSSG-UHFFFAOYSA-N 0.000 description 1
• YMZKCDMMGGVXGG-UHFFFAOYSA-N 4-[(2-fluorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C(=CC=CC=2)F)=C1 YMZKCDMMGGVXGG-UHFFFAOYSA-N 0.000 description 1
• GDGBYVVANSAXCF-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=C(Cl)C(Cl)=CC=2)=C1 GDGBYVVANSAXCF-UHFFFAOYSA-N 0.000 description 1
• LUOGWXNUEGYDRN-UHFFFAOYSA-N 4-[(3,5-dichlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=C(Cl)C=C(Cl)C=2)=C1 LUOGWXNUEGYDRN-UHFFFAOYSA-N 0.000 description 1
• VBTCVGBDAPONCJ-UHFFFAOYSA-N 4-[(3-bromophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=C(Br)C=CC=2)=C1 VBTCVGBDAPONCJ-UHFFFAOYSA-N 0.000 description 1
• KMLDLJNFCQSSBJ-UHFFFAOYSA-N 4-[(3-chlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=C(Cl)C=CC=2)=C1 KMLDLJNFCQSSBJ-UHFFFAOYSA-N 0.000 description 1
• CIVJFQMEVFHRND-UHFFFAOYSA-N 4-[(3-fluorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=C(F)C=CC=2)=C1 CIVJFQMEVFHRND-UHFFFAOYSA-N 0.000 description 1
• NQNIWFINWBIKCQ-UHFFFAOYSA-N 4-[(4-chlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=CC(Cl)=CC=2)=C1 NQNIWFINWBIKCQ-UHFFFAOYSA-N 0.000 description 1
• VJAOKBWYFLBXDE-UHFFFAOYSA-N 4-[3-(3-chlorophenyl)propylamino]-n-ethoxypyridine-2-carboxamide Chemical compound C1=NC(C(=O)NOCC)=CC(NCCCC=2C=C(Cl)C=CC=2)=C1 VJAOKBWYFLBXDE-UHFFFAOYSA-N 0.000 description 1
• QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
• FPAFKIZTFIVTCJ-UHFFFAOYSA-N 4-[benzylsulfonyl(methyl)amino]-n-hydroxypyridine-2-carboxamide Chemical compound C=1C=CC=CC=1CS(=O)(=O)N(C)C1=CC=NC(C(=O)NO)=C1 FPAFKIZTFIVTCJ-UHFFFAOYSA-N 0.000 description 1
• BYXQYMKTBUUTHK-UHFFFAOYSA-N 4-amino-N-ethoxypyridine-2-carboxamide hypochlorous acid Chemical compound ClO.CCONC(=O)C1=CC(N)=CC=N1 BYXQYMKTBUUTHK-UHFFFAOYSA-N 0.000 description 1
• OKJDLVAAPAUEAC-UHFFFAOYSA-N 4-azido-n-benzyl-n-(oxan-2-yloxy)pyridine-2-carboxamide Chemical compound [N-]=[N+]=NC1=CC=NC(C(=O)N(CC=2C=CC=CC=2)OC2OCCCC2)=C1 OKJDLVAAPAUEAC-UHFFFAOYSA-N 0.000 description 1
• VPTSCJNBTXTMHR-UHFFFAOYSA-N 4-azidopyridine-2-carboxylic acid Chemical compound OC(=O)c1cc(ccn1)N=[N+]=[N-] VPTSCJNBTXTMHR-UHFFFAOYSA-N 0.000 description 1
• HIZVHWZQEVZONK-UHFFFAOYSA-N 4-benzamido-n-hydroxypyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(NC(=O)C=2C=CC=CC=2)=C1 HIZVHWZQEVZONK-UHFFFAOYSA-N 0.000 description 1
• NNMYRMGMVLMQAY-UHFFFAOYSA-N 4-chloropyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC(Cl)=CC=N1 NNMYRMGMVLMQAY-UHFFFAOYSA-N 0.000 description 1
• LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
• IXENWFQXVCOHAZ-UHFFFAOYSA-N 4-fluoropiperidine;hydrochloride Chemical compound Cl.FC1CCNCC1 IXENWFQXVCOHAZ-UHFFFAOYSA-N 0.000 description 1
• STWODXDTKGTVCJ-UHFFFAOYSA-N 4-pyrrolidin-1-ylpiperidine Chemical compound C1CCCN1C1CCNCC1 STWODXDTKGTVCJ-UHFFFAOYSA-N 0.000 description 1
• SXTSYQLHRGJPET-UHFFFAOYSA-N 5-(3-formylphenyl)pyridine-2-carbonitrile Chemical compound O=CC1=CC=CC(C=2C=NC(=CC=2)C#N)=C1 SXTSYQLHRGJPET-UHFFFAOYSA-N 0.000 description 1
• IFLCAKMPPRCRCG-UHFFFAOYSA-N 5-(3-methylphenyl)pyridine-2-carboxylic acid Chemical compound CC1=CC=CC(C=2C=NC(=CC=2)C(O)=O)=C1 IFLCAKMPPRCRCG-UHFFFAOYSA-N 0.000 description 1
• KUKVREZMBGVNRM-UHFFFAOYSA-N 5-[3-[(3-phenylpropylamino)methyl]phenyl]pyridine-2-carbonitrile Chemical compound C1=NC(C#N)=CC=C1C1=CC=CC(CNCCCC=2C=CC=CC=2)=C1 KUKVREZMBGVNRM-UHFFFAOYSA-N 0.000 description 1
• MMQPFUSDRXXFCX-UHFFFAOYSA-N 5-bromo-n-[(2-methylpropan-2-yl)oxy]-n-(2-phenylethyl)pyridine-2-carboxamide Chemical compound C=1C=C(Br)C=NC=1C(=O)N(OC(C)(C)C)CCC1=CC=CC=C1 MMQPFUSDRXXFCX-UHFFFAOYSA-N 0.000 description 1
• MNNQIBXLAHVDDL-UHFFFAOYSA-N 5-bromopyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Br)C=N1 MNNQIBXLAHVDDL-UHFFFAOYSA-N 0.000 description 1
• ZWYMVSUFMHBMGA-UHFFFAOYSA-N 5-phenyl-n-phenylmethoxypyridine-2-carboxamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=NC=1C(=O)NOCC1=CC=CC=C1 ZWYMVSUFMHBMGA-UHFFFAOYSA-N 0.000 description 1
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
• CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 241000702423 Adeno-associated virus - 2 Species 0.000 description 1
• 241000202702 Adeno-associated virus - 3 Species 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
• 241001115070 Bornavirus Species 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
• OOTMCNDLXSXHKQ-UHFFFAOYSA-N C(=O)C=1C=C(C=CC1)C=1C=CC(=NC1)C#N.N1=C(C=CC=C1)C#N Chemical compound C(=O)C=1C=C(C=CC1)C=1C=CC(=NC1)C#N.N1=C(C=CC=C1)C#N OOTMCNDLXSXHKQ-UHFFFAOYSA-N 0.000 description 1
• FGYVYSCEFHTZJT-UHFFFAOYSA-N C(C)(C)(C)OC(=O)N1C(CNCC1)C1=CC(=NC=C1)C(N(O)CC1=CC=CC=C1)=O Chemical compound C(C)(C)(C)OC(=O)N1C(CNCC1)C1=CC(=NC=C1)C(N(O)CC1=CC=CC=C1)=O FGYVYSCEFHTZJT-UHFFFAOYSA-N 0.000 description 1
• KZJXCDHFVFIKHD-UHFFFAOYSA-N C(C)(C)(C)ON(C(=O)C1=NC=CC=C1)CCC1=CC=CC=C1.BrC=1C=CC=NC1 Chemical compound C(C)(C)(C)ON(C(=O)C1=NC=CC=C1)CCC1=CC=CC=C1.BrC=1C=CC=NC1 KZJXCDHFVFIKHD-UHFFFAOYSA-N 0.000 description 1
• ZHLPIFHYNKVJLU-UHFFFAOYSA-N C(C)(C)(C)ON(C(=O)C1=NC=CC=C1C1=CC(=CC=C1)C(C)C)CCC1=CC=CC=C1 Chemical compound C(C)(C)(C)ON(C(=O)C1=NC=CC=C1C1=CC(=CC=C1)C(C)C)CCC1=CC=CC=C1 ZHLPIFHYNKVJLU-UHFFFAOYSA-N 0.000 description 1
• WYSFNVJDXJSNRS-UHFFFAOYSA-N C(C)OC(=O)C1=C(SC(=C1)C1=CC=CC=C1)NC(=O)OC(C)(C)C.C(C)(C)(C)OC(=O)NC=1SC(=CC1C(=O)O)C1=CC=CC=C1 Chemical compound C(C)OC(=O)C1=C(SC(=C1)C1=CC=CC=C1)NC(=O)OC(C)(C)C.C(C)(C)(C)OC(=O)NC=1SC(=CC1C(=O)O)C1=CC=CC=C1 WYSFNVJDXJSNRS-UHFFFAOYSA-N 0.000 description 1
• MCIHCAPTSWWWKL-UHFFFAOYSA-N C(C)OC(=O)N1C(SC=C1C)NC(=O)OC(C)(C)C Chemical compound C(C)OC(=O)N1C(SC=C1C)NC(=O)OC(C)(C)C MCIHCAPTSWWWKL-UHFFFAOYSA-N 0.000 description 1
• IUVULNRTXUUIDW-UHFFFAOYSA-N C(C1=CC=CC=C1)N(C(=O)C1=NC=CC=C1)OC1OCCCC1 Chemical compound C(C1=CC=CC=C1)N(C(=O)C1=NC=CC=C1)OC1OCCCC1 IUVULNRTXUUIDW-UHFFFAOYSA-N 0.000 description 1
• RWHONIVKMLLZNB-UHFFFAOYSA-N C(C1=CC=CC=C1)NOC1OCCCC1 Chemical compound C(C1=CC=CC=C1)NOC1OCCCC1 RWHONIVKMLLZNB-UHFFFAOYSA-N 0.000 description 1
• SSNZGGJPQCBMQU-UHFFFAOYSA-L C1(=CC=CC=C1)C.C([O-])([O-])=O.[Cs+].[Cs+] Chemical compound C1(=CC=CC=C1)C.C([O-])([O-])=O.[Cs+].[Cs+] SSNZGGJPQCBMQU-UHFFFAOYSA-L 0.000 description 1
• IGNONURZNPPDDJ-UHFFFAOYSA-N C1(CCCCC1)NC1NC=C2C(=N1)SC(=C2C)C2=CC=CC=C2 Chemical compound C1(CCCCC1)NC1NC=C2C(=N1)SC(=C2C)C2=CC=CC=C2 IGNONURZNPPDDJ-UHFFFAOYSA-N 0.000 description 1
• ZCVNYPBMGXENTA-UHFFFAOYSA-K C1(CCCCC1)P(C1=C(C=CC=C1)C1=C(C=CC=C1OC)OC)C1CCCCC1.P(=O)([O-])([O-])[O-].[K+].[K+].[K+] Chemical group C1(CCCCC1)P(C1=C(C=CC=C1)C1=C(C=CC=C1OC)OC)C1CCCCC1.P(=O)([O-])([O-])[O-].[K+].[K+].[K+] ZCVNYPBMGXENTA-UHFFFAOYSA-K 0.000 description 1
• VRXPRAJHWUOGMQ-UHFFFAOYSA-N CC(C)C1=CC=CC(C2=CC(N)=CC(C(C)C)=C2)=C1 Chemical compound CC(C)C1=CC=CC(C2=CC(N)=CC(C(C)C)=C2)=C1 VRXPRAJHWUOGMQ-UHFFFAOYSA-N 0.000 description 1
• SVPCXKZGQGBZQC-UHFFFAOYSA-N CCC(C)ON1C(C2=NC=C(C=C2C1)C1=CC(=CC=C1)C(C)C)=O Chemical compound CCC(C)ON1C(C2=NC=C(C=C2C1)C1=CC(=CC=C1)C(C)C)=O SVPCXKZGQGBZQC-UHFFFAOYSA-N 0.000 description 1
• ZSBIMZZTAHDUCH-UHFFFAOYSA-N CN(C)C=1C(=C(C=CC1)B(O)O)C Chemical compound CN(C)C=1C(=C(C=CC1)B(O)O)C ZSBIMZZTAHDUCH-UHFFFAOYSA-N 0.000 description 1
• BCYHZJZBCVLUGQ-UHFFFAOYSA-N CN1C(N=C2C(=C1)C=C(S2)C2=CC=CC=C2)N2CCOCC2 Chemical compound CN1C(N=C2C(=C1)C=C(S2)C2=CC=CC=C2)N2CCOCC2 BCYHZJZBCVLUGQ-UHFFFAOYSA-N 0.000 description 1
• VGMWRENYHIBFGH-UHFFFAOYSA-N CN1C(N=C2C(=C1)C=C(S2)C2=CC=CC=C2)NC2=CC=CC=C2 Chemical compound CN1C(N=C2C(=C1)C=C(S2)C2=CC=CC=C2)NC2=CC=CC=C2 VGMWRENYHIBFGH-UHFFFAOYSA-N 0.000 description 1
• GMFNFTQXPVPZHD-UHFFFAOYSA-N CN1C(N=C2C(=C1)C=C(S2)C2=CC=CC=C2)NCCN2CCOCC2 Chemical compound CN1C(N=C2C(=C1)C=C(S2)C2=CC=CC=C2)NCCN2CCOCC2 GMFNFTQXPVPZHD-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241001493160 California encephalitis virus Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 241001502567 Chikungunya virus Species 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• XIYQJKMNHATRKD-UHFFFAOYSA-N ClO.C1=NC(C(=O)NOCC)=CC(NCC2CCN(CC=3C=CC=CC=3)CC2)=C1 Chemical compound ClO.C1=NC(C(=O)NOCC)=CC(NCC2CCN(CC=3C=CC=CC=3)CC2)=C1 XIYQJKMNHATRKD-UHFFFAOYSA-N 0.000 description 1
• HCYZDNHEVGXDPW-UHFFFAOYSA-N ClO.C1=NC(C(=O)NOCC)=CC=C1C1=CC=CC(CN(C)CC=2C=CC=CC=2)=C1 Chemical compound ClO.C1=NC(C(=O)NOCC)=CC=C1C1=CC=CC(CN(C)CC=2C=CC=CC=2)=C1 HCYZDNHEVGXDPW-UHFFFAOYSA-N 0.000 description 1
• HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
• 241000204955 Colorado tick fever virus Species 0.000 description 1
• 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 241000104338 Delitschia confertaspora Species 0.000 description 1
• 241001533413 Deltavirus Species 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• 241000988559 Enterovirus A Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 1
• 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 241000531123 GB virus C Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 206010069767 H1N1 influenza Diseases 0.000 description 1
• 241000893570 Hendra henipavirus Species 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000724675 Hepatitis E virus Species 0.000 description 1
• 241000709721 Hepatovirus A Species 0.000 description 1
• 244000309467 Human Coronavirus Species 0.000 description 1
• 241000598171 Human adenovirus sp. Species 0.000 description 1
• 241000724642 Human astrovirus 1 Species 0.000 description 1
• 241001207270 Human enterovirus Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
• 241001661732 Isavirus Species 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 229940122142 Lipoxygenase inhibitor Drugs 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 241000712898 Machupo mammarenavirus Species 0.000 description 1
• 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 206010027201 Meningitis aseptic Diseases 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 241000725171 Mokola lyssavirus Species 0.000 description 1
• NWVXECCQHINNFX-UHFFFAOYSA-N N-[(2-methylpropan-2-yl)oxy]hydroxylamine hydrochloride Chemical compound Cl.CC(C)(C)ONO NWVXECCQHINNFX-UHFFFAOYSA-N 0.000 description 1
• PQRCVQGIKXQWNX-UHFFFAOYSA-N N-benzylhydroxylamine 4-[(3-chlorophenyl)methylsulfonylamino]pyridine-2-carboxylic acid hydrochloride Chemical compound Cl.ONCC1=CC=CC=C1.C1=NC(C(=O)O)=CC(NS(=O)(=O)CC=2C=C(Cl)C=CC=2)=C1 PQRCVQGIKXQWNX-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• VYUNHRGXJJAVKM-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2)CC2=CC=CC=C2 Chemical compound NC1NC=C2C(=N1)SC(=C2)CC2=CC=CC=C2 VYUNHRGXJJAVKM-UHFFFAOYSA-N 0.000 description 1
• JMBZSNVPRVRISD-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2Br)C2=CC=CC=C2 Chemical compound NC1NC=C2C(=N1)SC(=C2Br)C2=CC=CC=C2 JMBZSNVPRVRISD-UHFFFAOYSA-N 0.000 description 1
• SUMSPYDOTNFAKE-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C(=CC=C2)Cl)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C(=CC=C2)Cl)F SUMSPYDOTNFAKE-UHFFFAOYSA-N 0.000 description 1
• XSGADOISTTVMMG-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C(=CC=C2F)Cl)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C(=CC=C2F)Cl)F XSGADOISTTVMMG-UHFFFAOYSA-N 0.000 description 1
• IXDFEPBCLSNREB-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C=C(C=C2)Cl)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C=C(C=C2)Cl)F IXDFEPBCLSNREB-UHFFFAOYSA-N 0.000 description 1
• RYLOOALRNASLNJ-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C=C(C=C2)F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C=C(C=C2)F)F RYLOOALRNASLNJ-UHFFFAOYSA-N 0.000 description 1
• VUKATWCOKVQJSB-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C=CC(=C2)CN(C)C)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C=CC(=C2)CN(C)C)F VUKATWCOKVQJSB-UHFFFAOYSA-N 0.000 description 1
• NNIPAQFMJHFUSL-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C=CC=C2)Cl Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C=CC=C2)Cl NNIPAQFMJHFUSL-UHFFFAOYSA-N 0.000 description 1
• CLDCLWHGQAPZOM-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=C(C=CC=C2)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=C(C=CC=C2)F CLDCLWHGQAPZOM-UHFFFAOYSA-N 0.000 description 1
• WEFKALSSFPNOTF-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=C(C=C2)Cl)C(F)(F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=C(C=C2)Cl)C(F)(F)F WEFKALSSFPNOTF-UHFFFAOYSA-N 0.000 description 1
• PFPRSSRMFYHAFH-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=C(C=C2)Cl)O Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=C(C=C2)Cl)O PFPRSSRMFYHAFH-UHFFFAOYSA-N 0.000 description 1
• VAOVVPQMCQSVGY-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=C(C=C2)F)C(F)(F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=C(C=C2)F)C(F)(F)F VAOVVPQMCQSVGY-UHFFFAOYSA-N 0.000 description 1
• MLQCMOLFERUVCD-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F MLQCMOLFERUVCD-UHFFFAOYSA-N 0.000 description 1
• MBEIKPFBHWBIAG-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC=C2)C(F)(F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC=C2)C(F)(F)F MBEIKPFBHWBIAG-UHFFFAOYSA-N 0.000 description 1
• BWILUNLODCERFB-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC=C2)CN(C)C Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC=C2)CN(C)C BWILUNLODCERFB-UHFFFAOYSA-N 0.000 description 1
• RYPMRWZQAHXSMD-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC=C2)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=CC=C2)F RYPMRWZQAHXSMD-UHFFFAOYSA-N 0.000 description 1
• CEBPNGWRRSQQAX-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC(=NC=C2)C(F)(F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC(=NC=C2)C(F)(F)F CEBPNGWRRSQQAX-UHFFFAOYSA-N 0.000 description 1
• RKDUCPBZILCGTO-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)C Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)C RKDUCPBZILCGTO-UHFFFAOYSA-N 0.000 description 1
• NELOYWBFIJEIEM-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)Cl Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)Cl NELOYWBFIJEIEM-UHFFFAOYSA-N 0.000 description 1
• MQRNLIRGBOYALB-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)F MQRNLIRGBOYALB-UHFFFAOYSA-N 0.000 description 1
• ZOWXTDRXZGBEQO-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)OC Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC=C(C=C2)OC ZOWXTDRXZGBEQO-UHFFFAOYSA-N 0.000 description 1
• LKSVHDKXXMRZPL-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=CC=NC=C2 Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=CC=NC=C2 LKSVHDKXXMRZPL-UHFFFAOYSA-N 0.000 description 1
• ZDTAIOVWMNXXSE-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=NC(N=C2)C Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=NC(N=C2)C ZDTAIOVWMNXXSE-UHFFFAOYSA-N 0.000 description 1
• PKICHIKZAIONFX-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C2=NC=CN=C2 Chemical compound NC1NC=C2C(=N1)SC(=C2C)C2=NC=CN=C2 PKICHIKZAIONFX-UHFFFAOYSA-N 0.000 description 1
• IUIDYAUKFFMCKN-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C=2C(=NC(=CC2)F)F Chemical compound NC1NC=C2C(=N1)SC(=C2C)C=2C(=NC(=CC2)F)F IUIDYAUKFFMCKN-UHFFFAOYSA-N 0.000 description 1
• BYNJOBPEHWHRFJ-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C=2C=C(C=CC2)C Chemical compound NC1NC=C2C(=N1)SC(=C2C)C=2C=C(C=CC2)C BYNJOBPEHWHRFJ-UHFFFAOYSA-N 0.000 description 1
• RMJVIKGFIRJZTM-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C=2C=NC(=CC2)Cl Chemical compound NC1NC=C2C(=N1)SC(=C2C)C=2C=NC(=CC2)Cl RMJVIKGFIRJZTM-UHFFFAOYSA-N 0.000 description 1
• QOUYAUIHQNFZKT-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C=2C=NC=CC2 Chemical compound NC1NC=C2C(=N1)SC(=C2C)C=2C=NC=CC2 QOUYAUIHQNFZKT-UHFFFAOYSA-N 0.000 description 1
• BBKZIDWSFNPWDX-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)C=2CCNCC2 Chemical compound NC1NC=C2C(=N1)SC(=C2C)C=2CCNCC2 BBKZIDWSFNPWDX-UHFFFAOYSA-N 0.000 description 1
• CKPMGFRUFNDZAZ-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)CC2=CC=C(C=C2)Cl Chemical compound NC1NC=C2C(=N1)SC(=C2C)CC2=CC=C(C=C2)Cl CKPMGFRUFNDZAZ-UHFFFAOYSA-N 0.000 description 1
• IQHXAOOJNDYAHO-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2C)CC2=CC=CC=C2 Chemical compound NC1NC=C2C(=N1)SC(=C2C)CC2=CC=CC=C2 IQHXAOOJNDYAHO-UHFFFAOYSA-N 0.000 description 1
• BSUKIZYFLBJDLN-UHFFFAOYSA-N NC1NC=C2C(=N1)SC(=C2Cl)C2=CC=CC=C2 Chemical compound NC1NC=C2C(=N1)SC(=C2Cl)C2=CC=CC=C2 BSUKIZYFLBJDLN-UHFFFAOYSA-N 0.000 description 1
• 241001263478 Norovirus Species 0.000 description 1
• TXVKJRDBZHUQCX-UHFFFAOYSA-N OC(C1=NC=CC=C1C1=CCCCC1)=O.ONCC1=CC=CC=C1 Chemical compound OC(C1=NC=CC=C1C1=CCCCC1)=O.ONCC1=CC=CC=C1 TXVKJRDBZHUQCX-UHFFFAOYSA-N 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 1
• 101150020891 PRKCA gene Proteins 0.000 description 1
• YNHIGQDRGKUECZ-UHFFFAOYSA-L PdCl2(PPh3)2 Substances [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
• 241000255129 Phlebotominae Species 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 229920003081 Povidone K 30 Polymers 0.000 description 1
• 102000029797 Prion Human genes 0.000 description 1
• 108091000054 Prion Proteins 0.000 description 1
• WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
• 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
• 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 241000702263 Reovirus sp. Species 0.000 description 1
• 102000004389 Ribonucleoproteins Human genes 0.000 description 1
• 108010081734 Ribonucleoproteins Proteins 0.000 description 1
• 241001137860 Rotavirus A Species 0.000 description 1
• 241001137861 Rotavirus B Species 0.000 description 1
• 241000149820 Sakhalin orthonairovirus Species 0.000 description 1
• 241000150278 Seoul orthohantavirus Species 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
• 101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 1
• 239000004147 Sorbitan trioleate Substances 0.000 description 1
• PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 229920002253 Tannate Polymers 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 241000711975 Vesicular stomatitis virus Species 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 208000000260 Warts Diseases 0.000 description 1
• ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
• PHLLTVDZCKUNJN-UHFFFAOYSA-N [2-(trifluoromethyl)pyridin-4-yl]boronic acid Chemical compound OB(O)C1=CC=NC(C(F)(F)F)=C1 PHLLTVDZCKUNJN-UHFFFAOYSA-N 0.000 description 1
• BPTABBGLHGBJQR-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 BPTABBGLHGBJQR-UHFFFAOYSA-N 0.000 description 1
• DCXXIDMHTQDSLY-UHFFFAOYSA-N [3-(dimethylcarbamoyl)phenyl]boronic acid Chemical compound CN(C)C(=O)C1=CC=CC(B(O)O)=C1 DCXXIDMHTQDSLY-UHFFFAOYSA-N 0.000 description 1
• HGTDLKXUWVKLQX-UHFFFAOYSA-N [3-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC=CC(B(O)O)=C1 HGTDLKXUWVKLQX-UHFFFAOYSA-N 0.000 description 1
• FYFFPNFUVMBPRZ-UHFFFAOYSA-N [3-(methylcarbamoyl)phenyl]boronic acid Chemical compound CNC(=O)C1=CC=CC(B(O)O)=C1 FYFFPNFUVMBPRZ-UHFFFAOYSA-N 0.000 description 1
• WGZQGJKHTBTXLD-UHFFFAOYSA-N [3-[2-(dimethylamino)ethylcarbamoyl]phenyl]boronic acid Chemical compound CN(C)CCNC(=O)C1=CC=CC(B(O)O)=C1 WGZQGJKHTBTXLD-UHFFFAOYSA-N 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• XHKNQBNGLMOTDB-UHFFFAOYSA-N [4-chloro-3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(C(F)(F)F)=C1 XHKNQBNGLMOTDB-UHFFFAOYSA-N 0.000 description 1
• GUJYFCBXDUPORN-UHFFFAOYSA-N [4-fluoro-3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(F)C(C(F)(F)F)=C1 GUJYFCBXDUPORN-UHFFFAOYSA-N 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 125000002723 alicyclic group Chemical group 0.000 description 1
• 229910052783 alkali metal Inorganic materials 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
• 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
• 150000008052 alkyl sulfonates Chemical class 0.000 description 1
• 108010028144 alpha-Glucosidases Proteins 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000002155 anti-virotic effect Effects 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 239000008346 aqueous phase Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 229910052786 argon Inorganic materials 0.000 description 1
• 125000005228 aryl sulfonate group Chemical group 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 239000002585 base Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 239000000440 bentonite Substances 0.000 description 1
• 229910000278 bentonite Inorganic materials 0.000 description 1
• 235000012216 bentonite Nutrition 0.000 description 1
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
• 229940077388 benzenesulfonate Drugs 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
• QYCSNMDOZNUZIT-UHFFFAOYSA-N benzhydrylidenehydrazine Chemical compound C=1C=CC=CC=1C(=NN)C1=CC=CC=C1 QYCSNMDOZNUZIT-UHFFFAOYSA-N 0.000 description 1
• 229940050390 benzoate Drugs 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 1
• PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
• 125000002619 bicyclic group Chemical group 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 125000005998 bromoethyl group Chemical group 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
• 229910000024 caesium carbonate Inorganic materials 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000003556 cannabinoid 2 receptor agonist Substances 0.000 description 1
• 239000007894 caplet Substances 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 229950005499 carbon tetrachloride Drugs 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000007910 cell fusion Effects 0.000 description 1
• 238000012054 celltiter-glo Methods 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 229940090805 clavulanate Drugs 0.000 description 1
• HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
• 235000009508 confectionery Nutrition 0.000 description 1
• 229940111134 coxibs Drugs 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 229960001681 croscarmellose sodium Drugs 0.000 description 1
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
• 238000005564 crystal structure determination Methods 0.000 description 1
• 239000003260 cyclooxygenase 1 inhibitor Substances 0.000 description 1
• 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
• BALGDZWGNCXXES-UHFFFAOYSA-N cyclopentane;propanoic acid Chemical compound CCC(O)=O.C1CCCC1 BALGDZWGNCXXES-UHFFFAOYSA-N 0.000 description 1
• 150000001940 cyclopentanes Chemical class 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• SPCNPOWOBZQWJK-UHFFFAOYSA-N dimethoxy-(2-propan-2-ylsulfanylethylsulfanyl)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)SCCSC(C)C SPCNPOWOBZQWJK-UHFFFAOYSA-N 0.000 description 1
• OIKHZBFJHONJJB-UHFFFAOYSA-N dimethyl(phenyl)silicon Chemical compound C[Si](C)C1=CC=CC=C1 OIKHZBFJHONJJB-UHFFFAOYSA-N 0.000 description 1
• WUAUXPDYAQKEKT-UHFFFAOYSA-N diphenylmethanesulfonyl chloride Chemical compound C=1C=CC=CC=1C(S(=O)(=O)Cl)C1=CC=CC=C1 WUAUXPDYAQKEKT-UHFFFAOYSA-N 0.000 description 1
• 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 1
• 239000002612 dispersion medium Substances 0.000 description 1
• POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
• 229940000406 drug candidate Drugs 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 239000013583 drug formulation Substances 0.000 description 1
• 239000003596 drug target Substances 0.000 description 1
• 229940112141 dry powder inhaler Drugs 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 229940009662 edetate Drugs 0.000 description 1
• DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
• DGTQGILYTMBQJA-UHFFFAOYSA-N ethyl 2-amino-4-chloro-5-phenylthiophene-3-carboxylate Chemical compound CCOC(=O)C1=C(N)SC(C=2C=CC=CC=2)=C1Cl DGTQGILYTMBQJA-UHFFFAOYSA-N 0.000 description 1
• QQDPRGVPYOPPBA-UHFFFAOYSA-N ethyl 2-amino-4-methyl-5-(phenylcarbamoyl)thiophene-3-carboxylate Chemical compound CCOC(=O)C1=C(N)SC(C(=O)NC=2C=CC=CC=2)=C1C QQDPRGVPYOPPBA-UHFFFAOYSA-N 0.000 description 1
• FXPVOLWQNNGFHA-UHFFFAOYSA-N ethyl 2-amino-4-methyl-5-phenylthiophene-3-carboxylate Chemical compound CCOC(=O)C1=C(N)SC(C=2C=CC=CC=2)=C1C FXPVOLWQNNGFHA-UHFFFAOYSA-N 0.000 description 1
• ILYCZKOBLRJJSW-UHFFFAOYSA-N ethyl 2-amino-4-methylthiophene-3-carboxylate Chemical compound CCOC(=O)C=1C(C)=CSC=1N ILYCZKOBLRJJSW-UHFFFAOYSA-N 0.000 description 1
• HKAKABKUKJASLW-UHFFFAOYSA-N ethyl 2-amino-5-benzylthiophene-3-carboxylate Chemical compound S1C(N)=C(C(=O)OCC)C=C1CC1=CC=CC=C1 HKAKABKUKJASLW-UHFFFAOYSA-N 0.000 description 1
• WIVNPGXPJBBZQH-UHFFFAOYSA-N ethyl 2-amino-5-phenylthiophene-3-carboxylate Chemical compound S1C(N)=C(C(=O)OCC)C=C1C1=CC=CC=C1 WIVNPGXPJBBZQH-UHFFFAOYSA-N 0.000 description 1
• ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
• UWKHYLSGIOBOPO-UHFFFAOYSA-N ethyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate Chemical compound CCOC(=O)C=1C(C)=CSC=1NC(=O)OC(C)(C)C UWKHYLSGIOBOPO-UHFFFAOYSA-N 0.000 description 1
• RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
• 229940012017 ethylenediamine Drugs 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 229940014259 gelatin Drugs 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
• 239000010440 gypsum Substances 0.000 description 1
• 229910052602 gypsum Inorganic materials 0.000 description 1
• 150000004820 halides Chemical class 0.000 description 1
• 239000000416 hydrocolloid Substances 0.000 description 1
• 150000005828 hydrofluoroalkanes Chemical class 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• RGZRSLKIOCHTSI-UHFFFAOYSA-N hydron;n-methylhydroxylamine;chloride Chemical compound Cl.CNO RGZRSLKIOCHTSI-UHFFFAOYSA-N 0.000 description 1
• 150000004679 hydroxides Chemical class 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
• APRUFHWBZLCUDA-UHFFFAOYSA-N hydroxylamine;oxolane Chemical compound ON.C1CCOC1 APRUFHWBZLCUDA-UHFFFAOYSA-N 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 239000007951 isotonicity adjuster Substances 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 229940001447 lactate Drugs 0.000 description 1
• 229940099584 lactobionate Drugs 0.000 description 1
• JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 229940070765 laurate Drugs 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 208000001419 lymphocytic choriomeningitis Diseases 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 229910000474 mercury oxide Inorganic materials 0.000 description 1
• UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• FLGJKAWEVKYTSD-UHFFFAOYSA-N methyl 2-amino-5-(1-phenylethyl)thiophene-3-carboxylate Chemical compound S1C(N)=C(C(=O)OC)C=C1C(C)C1=CC=CC=C1 FLGJKAWEVKYTSD-UHFFFAOYSA-N 0.000 description 1
• GNDXRTHPMSTCQP-UHFFFAOYSA-N methyl 2-amino-5-propan-2-ylthiophene-3-carboxylate Chemical compound COC(=O)C=1C=C(C(C)C)SC=1N GNDXRTHPMSTCQP-UHFFFAOYSA-N 0.000 description 1
• CSOYXVVFFMZNRL-UHFFFAOYSA-N methyl 4-(benzhydrylsulfonylamino)pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(NS(=O)(=O)C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 CSOYXVVFFMZNRL-UHFFFAOYSA-N 0.000 description 1
• BBSJNABQRZEWAF-UHFFFAOYSA-N methyl 4-(benzylsulfonylamino)pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(NS(=O)(=O)CC=2C=CC=CC=2)=C1 BBSJNABQRZEWAF-UHFFFAOYSA-N 0.000 description 1
• KCWTZNZNBIRWQU-UHFFFAOYSA-N methyl 4-[3-(3-chlorophenyl)propylamino]pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(NCCCC=2C=C(Cl)C=CC=2)=C1 KCWTZNZNBIRWQU-UHFFFAOYSA-N 0.000 description 1
• XDSAZNLKWCJKCT-UHFFFAOYSA-N methyl 4-[benzyl(methyl)amino]pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(N(C)CC=2C=CC=CC=2)=C1 XDSAZNLKWCJKCT-UHFFFAOYSA-N 0.000 description 1
• AMTDRTFUUIVPAN-UHFFFAOYSA-N methyl 4-[benzylsulfonyl(methyl)amino]pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(N(C)S(=O)(=O)CC=2C=CC=CC=2)=C1 AMTDRTFUUIVPAN-UHFFFAOYSA-N 0.000 description 1
• JZFLATQBIPILFS-UHFFFAOYSA-N methyl 4-bromopyridine-2-carboxylate Chemical compound COC(=O)C1=CC(Br)=CC=N1 JZFLATQBIPILFS-UHFFFAOYSA-N 0.000 description 1
• KZPOANNAYCXMSH-UHFFFAOYSA-N methyl 5-bromo-3-methylpyridine-2-carboxylate Chemical compound COC(=O)C1=NC=C(Br)C=C1C KZPOANNAYCXMSH-UHFFFAOYSA-N 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• VYHVQEYOFIYNJP-UHFFFAOYSA-N methyl thiocyanate Chemical compound CSC#N VYHVQEYOFIYNJP-UHFFFAOYSA-N 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
• 235000018342 monosodium citrate Nutrition 0.000 description 1
• 239000002524 monosodium citrate Substances 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
• AGQFCLJUFIQFKK-UHFFFAOYSA-N n,6-dimethyl-n-phenylmethoxypyridine-2-carboxamide Chemical compound C=1C=CC(C)=NC=1C(=O)N(C)OCC1=CC=CC=C1 AGQFCLJUFIQFKK-UHFFFAOYSA-N 0.000 description 1
• YFJAIURZMRJPDB-UHFFFAOYSA-N n,n-dimethylpiperidin-4-amine Chemical compound CN(C)C1CCNCC1 YFJAIURZMRJPDB-UHFFFAOYSA-N 0.000 description 1
• MXXMJJSIJDMYJZ-UHFFFAOYSA-N n-(2-phenylethyl)hydroxylamine Chemical compound ONCCC1=CC=CC=C1 MXXMJJSIJDMYJZ-UHFFFAOYSA-N 0.000 description 1
• BKTJTCQDFAAHJE-UHFFFAOYSA-N n-[(2-methylpropan-2-yl)oxy]-n-(2-phenylethyl)-5-(3-propan-2-ylphenyl)pyridine-2-carboxamide Chemical compound CC(C)C1=CC=CC(C=2C=NC(=CC=2)C(=O)N(CCC=2C=CC=CC=2)OC(C)(C)C)=C1 BKTJTCQDFAAHJE-UHFFFAOYSA-N 0.000 description 1
• YPOINGKYOHHDGI-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-n-hydroxy-4-phenylpyridine-2-carboxamide Chemical compound C=1C(C=2C=CC=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=C(F)C=C1 YPOINGKYOHHDGI-UHFFFAOYSA-N 0.000 description 1
• RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 1
• DUNNSAMLPSKWOD-UHFFFAOYSA-N n-benzyl-4-(3,3-difluoropyrrolidin-1-yl)-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C=1C(N2CC(F)(F)CC2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 DUNNSAMLPSKWOD-UHFFFAOYSA-N 0.000 description 1
• YTFJPPLZVBCCFS-UHFFFAOYSA-N n-benzyl-4-(3,4-dichlorophenyl)-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(C=2C=C(Cl)C(Cl)=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 YTFJPPLZVBCCFS-UHFFFAOYSA-N 0.000 description 1
• FCMRIFLWGXFSPM-UHFFFAOYSA-N n-benzyl-4-(3-carbamoylphenyl)-n-hydroxypyridine-2-carboxamide Chemical compound NC(=O)C1=CC=CC(C=2C=C(N=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 FCMRIFLWGXFSPM-UHFFFAOYSA-N 0.000 description 1
• ARXFVJHWQTWRIP-UHFFFAOYSA-N n-benzyl-4-(4-carbamoylphenyl)-n-hydroxypyridine-2-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CC=NC(C(=O)N(O)CC=2C=CC=CC=2)=C1 ARXFVJHWQTWRIP-UHFFFAOYSA-N 0.000 description 1
• UXMUNRLTVOGMCA-UHFFFAOYSA-N n-benzyl-4-(4-chlorophenyl)-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(C=2C=CC(Cl)=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 UXMUNRLTVOGMCA-UHFFFAOYSA-N 0.000 description 1
• KKDHFTRWRJHPSK-UHFFFAOYSA-N n-benzyl-4-(benzylsulfonylamino)-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(NS(=O)(=O)CC=2C=CC=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 KKDHFTRWRJHPSK-UHFFFAOYSA-N 0.000 description 1
• HOLKKUIHGZQNNY-UHFFFAOYSA-N n-benzyl-4-(cyclohexen-1-yl)-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(C=2CCCCC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 HOLKKUIHGZQNNY-UHFFFAOYSA-N 0.000 description 1
• ZVIKNBFKTLWTHY-UHFFFAOYSA-N n-benzyl-4-[(3,5-dichlorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C=1C(NS(=O)(=O)CC=2C=C(Cl)C=C(Cl)C=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 ZVIKNBFKTLWTHY-UHFFFAOYSA-N 0.000 description 1
• SKARLRFGAWAGET-UHFFFAOYSA-N n-benzyl-4-[(3-fluorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C=1C(NS(=O)(=O)CC=2C=C(F)C=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 SKARLRFGAWAGET-UHFFFAOYSA-N 0.000 description 1
• TWAWIMZDXZMGPF-UHFFFAOYSA-N n-benzyl-4-[(4-fluorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(NS(=O)(=O)CC=2C=CC(F)=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 TWAWIMZDXZMGPF-UHFFFAOYSA-N 0.000 description 1
• OLPMQCLWEYQZMZ-UHFFFAOYSA-N n-benzyl-4-[(4-fluorophenyl)methylsulfonylamino]-n-hydroxypyridine-2-carboxamide;hydrochloride Chemical compound Cl.C=1C(NS(=O)(=O)CC=2C=CC(F)=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 OLPMQCLWEYQZMZ-UHFFFAOYSA-N 0.000 description 1
• CBZQFJKWHUVUMY-UHFFFAOYSA-N n-benzyl-4-[3-(dimethylcarbamoyl)phenyl]-n-hydroxypyridine-2-carboxamide Chemical compound CN(C)C(=O)C1=CC=CC(C=2C=C(N=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 CBZQFJKWHUVUMY-UHFFFAOYSA-N 0.000 description 1
• HJCRUHHDJHKTPQ-UHFFFAOYSA-N n-benzyl-4-[3-(dimethylsulfamoyl)phenyl]-n-hydroxypyridine-2-carboxamide Chemical compound CN(C)S(=O)(=O)C1=CC=CC(C=2C=C(N=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 HJCRUHHDJHKTPQ-UHFFFAOYSA-N 0.000 description 1
• AAOPJRWOIVFCLJ-UHFFFAOYSA-N n-benzyl-4-[3-[2-(dimethylamino)ethylcarbamoyl]phenyl]-n-hydroxypyridine-2-carboxamide Chemical compound CN(C)CCNC(=O)C1=CC=CC(C=2C=C(N=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 AAOPJRWOIVFCLJ-UHFFFAOYSA-N 0.000 description 1
• HBRKUXYIKCOXIK-UHFFFAOYSA-N n-benzyl-4-[benzyl(methyl)amino]-n-hydroxypyridine-2-carboxamide Chemical compound C=1C=NC(C(=O)N(O)CC=2C=CC=CC=2)=CC=1N(C)CC1=CC=CC=C1 HBRKUXYIKCOXIK-UHFFFAOYSA-N 0.000 description 1
• ZXKLURWKUWGWJP-UHFFFAOYSA-N n-benzyl-4-bromo-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(Br)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 ZXKLURWKUWGWJP-UHFFFAOYSA-N 0.000 description 1
• CWABNFXNLRCUER-UHFFFAOYSA-N n-benzyl-4-cyclohexyl-n-hydroxypyridine-2-carboxamide Chemical compound C=1C(C2CCCCC2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 CWABNFXNLRCUER-UHFFFAOYSA-N 0.000 description 1
• SAZSNDHPVFNVPZ-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-(4-methylpiperazin-1-yl)pyridine-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC=NC(C(=O)N(O)CC=2C=CC=CC=2)=C1 SAZSNDHPVFNVPZ-UHFFFAOYSA-N 0.000 description 1
• QCDIJYGDGJALSP-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-[3-(hydroxymethyl)phenyl]pyridine-2-carboxamide Chemical compound OCC1=CC=CC(C=2C=C(N=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 QCDIJYGDGJALSP-UHFFFAOYSA-N 0.000 description 1
• TYHXYALOLMJYJN-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-[3-(methylcarbamoyl)phenyl]pyridine-2-carboxamide Chemical compound CNC(=O)C1=CC=CC(C=2C=C(N=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 TYHXYALOLMJYJN-UHFFFAOYSA-N 0.000 description 1
• GKSPVPSSAPDGCD-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-[[3-(trifluoromethyl)phenyl]methylsulfonylamino]pyridine-2-carboxamide;hydrochloride Chemical compound Cl.C=1C(NS(=O)(=O)CC=2C=C(C=CC=2)C(F)(F)F)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 GKSPVPSSAPDGCD-UHFFFAOYSA-N 0.000 description 1
• JYWMUDMJFTXQIC-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-morpholin-4-ylpyridine-2-carboxamide Chemical compound C=1C(N2CCOCC2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 JYWMUDMJFTXQIC-UHFFFAOYSA-N 0.000 description 1
• VOROYXVSYSINQP-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-phenylpyridine-2-carboxamide Chemical compound C=1C(C=2C=CC=CC=2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 VOROYXVSYSINQP-UHFFFAOYSA-N 0.000 description 1
• SGGCKZWLHVQZEU-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-piperazin-1-ylpyridine-2-carboxamide;hydrochloride Chemical compound Cl.C=1C(N2CCNCC2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 SGGCKZWLHVQZEU-UHFFFAOYSA-N 0.000 description 1
• GDZKFIBPRUTACN-UHFFFAOYSA-N n-benzyl-n-hydroxy-4-piperidin-1-ylpyridine-2-carboxamide Chemical compound C=1C(N2CCCCC2)=CC=NC=1C(=O)N(O)CC1=CC=CC=C1 GDZKFIBPRUTACN-UHFFFAOYSA-N 0.000 description 1
• AUUNCBDDZDCCKU-UHFFFAOYSA-N n-benzyl-n-hydroxy-5-(3-methylphenyl)pyridine-2-carboxamide Chemical compound CC1=CC=CC(C=2C=NC(=CC=2)C(=O)N(O)CC=2C=CC=CC=2)=C1 AUUNCBDDZDCCKU-UHFFFAOYSA-N 0.000 description 1
• SNKLWTLVPOTVBZ-UHFFFAOYSA-N n-benzyl-n-hydroxy-5-piperidin-1-ylpyridine-2-carboxamide Chemical compound C=1C=C(N2CCCCC2)C=NC=1C(=O)N(O)CC1=CC=CC=C1 SNKLWTLVPOTVBZ-UHFFFAOYSA-N 0.000 description 1
• DJXDQXKCPCKIFS-UHFFFAOYSA-N n-benzyl-n-hydroxy-5-pyrrolidin-1-ylpyridine-2-carboxamide Chemical compound C=1C=C(N2CCCC2)C=NC=1C(=O)N(O)CC1=CC=CC=C1 DJXDQXKCPCKIFS-UHFFFAOYSA-N 0.000 description 1
• PXWGDTIMILPTAK-UHFFFAOYSA-N n-benzyl-n-hydroxyisoquinoline-3-carboxamide Chemical compound C=1C2=CC=CC=C2C=NC=1C(=O)N(O)CC1=CC=CC=C1 PXWGDTIMILPTAK-UHFFFAOYSA-N 0.000 description 1
• WBYTYMCYXYIOGX-UHFFFAOYSA-N n-benzyl-n-phenylmethoxy-5-pyrrolidin-1-ylpyridine-2-carboxamide Chemical compound C=1C=C(N2CCCC2)C=NC=1C(=O)N(OCC=1C=CC=CC=1)CC1=CC=CC=C1 WBYTYMCYXYIOGX-UHFFFAOYSA-N 0.000 description 1
• XZZNLSXUHJZDNI-UHFFFAOYSA-N n-ethoxy-4-[(3-phenylmethoxyphenyl)methylamino]pyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NOCC)=CC(NCC=2C=C(OCC=3C=CC=CC=3)C=CC=2)=C1 XZZNLSXUHJZDNI-UHFFFAOYSA-N 0.000 description 1
• LXXILONBJANELI-UHFFFAOYSA-N n-ethoxy-5-(3-propan-2-ylphenyl)pyridine-2-carboxamide Chemical compound C1=NC(C(=O)NOCC)=CC=C1C1=CC=CC(C(C)C)=C1 LXXILONBJANELI-UHFFFAOYSA-N 0.000 description 1
• VZGQXTLOAXGHCO-UHFFFAOYSA-N n-ethoxy-n,6-dimethylpyridine-2-carboxamide Chemical compound CCON(C)C(=O)C1=CC=CC(C)=N1 VZGQXTLOAXGHCO-UHFFFAOYSA-N 0.000 description 1
• FTFQSIGRXTXQCD-UHFFFAOYSA-N n-ethoxy-n-methyl-5-phenylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(C)OCC)=CC=C1C1=CC=CC=C1 FTFQSIGRXTXQCD-UHFFFAOYSA-N 0.000 description 1
• KNIJJZFXBMLOPC-UHFFFAOYSA-N n-ethoxypyridine-2-carboxamide Chemical compound CCONC(=O)C1=CC=CC=N1 KNIJJZFXBMLOPC-UHFFFAOYSA-N 0.000 description 1
• PKWZJIJQRIWUMS-UHFFFAOYSA-N n-hydroxy-3-(sulfonylamino)pyridine-2-carboxamide;hydrochloride Chemical compound Cl.ONC(=O)C1=NC=CC=C1N=S(=O)=O PKWZJIJQRIWUMS-UHFFFAOYSA-N 0.000 description 1
• CJILVXJBGZOFHV-UHFFFAOYSA-N n-hydroxy-4-(quinolin-8-ylmethylsulfonylamino)pyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C3=NC=CC=C3C=CC=2)=C1 CJILVXJBGZOFHV-UHFFFAOYSA-N 0.000 description 1
• DFMYAQOCURKAIR-UHFFFAOYSA-N n-hydroxy-4-[[3-(trifluoromethyl)phenyl]methylsulfonylamino]pyridine-2-carboxamide;hydrochloride Chemical compound Cl.C1=NC(C(=O)NO)=CC(NS(=O)(=O)CC=2C=C(C=CC=2)C(F)(F)F)=C1 DFMYAQOCURKAIR-UHFFFAOYSA-N 0.000 description 1
• MTASWHYEHYOTMD-UHFFFAOYSA-N n-hydroxy-4-morpholin-4-ylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(N2CCOCC2)=C1 MTASWHYEHYOTMD-UHFFFAOYSA-N 0.000 description 1
• OWZPJQARKASDLX-UHFFFAOYSA-N n-hydroxy-4-piperidin-1-ylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(N2CCCCC2)=C1 OWZPJQARKASDLX-UHFFFAOYSA-N 0.000 description 1
• ACDXIFJYNXVULR-UHFFFAOYSA-N n-hydroxy-5-(3-propan-2-ylphenyl)pyridine-2-carboxamide Chemical compound CC(C)C1=CC=CC(C=2C=NC(=CC=2)C(=O)NO)=C1 ACDXIFJYNXVULR-UHFFFAOYSA-N 0.000 description 1
• FJTMAJBZOXAIPN-UHFFFAOYSA-N n-hydroxy-5-phenylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC=C1C1=CC=CC=C1 FJTMAJBZOXAIPN-UHFFFAOYSA-N 0.000 description 1
• OFUIRMIPVHFNFG-UHFFFAOYSA-N n-hydroxy-5-pyrrolidin-1-ylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NO)=CC=C1N1CCCC1 OFUIRMIPVHFNFG-UHFFFAOYSA-N 0.000 description 1
• RBLVQYKCOCWCTL-UHFFFAOYSA-N n-hydroxy-n-(2-phenylethyl)-5-(3-propan-2-ylphenyl)pyridine-2-carboxamide Chemical compound CC(C)C1=CC=CC(C=2C=NC(=CC=2)C(=O)N(O)CCC=2C=CC=CC=2)=C1 RBLVQYKCOCWCTL-UHFFFAOYSA-N 0.000 description 1
• RDZHIOACDCQUEK-UHFFFAOYSA-N n-hydroxy-n-methylisoquinoline-3-carboxamide Chemical compound C1=CC=C2C=NC(C(=O)N(O)C)=CC2=C1 RDZHIOACDCQUEK-UHFFFAOYSA-N 0.000 description 1
• PDYHLDGWKQJXDD-UHFFFAOYSA-N n-hydroxyisoquinoline-3-carboxamide Chemical compound C1=CC=C2C=NC(C(=O)NO)=CC2=C1 PDYHLDGWKQJXDD-UHFFFAOYSA-N 0.000 description 1
• CVZITIVMSOJTEX-UHFFFAOYSA-N n-methyl-5-phenyl-n-phenylmethoxypyridine-2-carboxamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=NC=1C(=O)N(C)OCC1=CC=CC=C1 CVZITIVMSOJTEX-UHFFFAOYSA-N 0.000 description 1
• UGQKECARBQMABT-UHFFFAOYSA-N n-methyl-n-phenylmethoxyisoquinoline-3-carboxamide Chemical compound C=1C2=CC=CC=C2C=NC=1C(=O)N(C)OCC1=CC=CC=C1 UGQKECARBQMABT-UHFFFAOYSA-N 0.000 description 1
• FEXDWRIVBHDEDS-UHFFFAOYSA-N n-phenylmethoxy-4-piperidin-1-ylpyridine-2-carboxamide Chemical compound C=1C(N2CCCCC2)=CC=NC=1C(=O)NOCC1=CC=CC=C1 FEXDWRIVBHDEDS-UHFFFAOYSA-N 0.000 description 1
• OFYNSUXAPUNTDZ-UHFFFAOYSA-N n-phenylmethoxy-5-pyrrolidin-1-ylpyridine-2-carboxamide Chemical compound C=1C=C(N2CCCC2)C=NC=1C(=O)NOCC1=CC=CC=C1 OFYNSUXAPUNTDZ-UHFFFAOYSA-N 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 150000002823 nitrates Chemical class 0.000 description 1
• NLXXVSKHVGDQAT-UHFFFAOYSA-N o-(oxan-2-yl)hydroxylamine Chemical compound NOC1CCCCO1 NLXXVSKHVGDQAT-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 108700013356 oplunofusp Proteins 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
• PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 description 1
• 150000003891 oxalate salts Chemical class 0.000 description 1
• SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
• QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000008447 perception Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• CYJAWBVQRMVFEO-UHFFFAOYSA-N piperazine-2,6-dione Chemical class O=C1CNCC(=O)N1 CYJAWBVQRMVFEO-UHFFFAOYSA-N 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 125000003367 polycyclic group Chemical group 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 235000011056 potassium acetate Nutrition 0.000 description 1
• NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
• 159000000001 potassium salts Chemical class 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 1
• 239000011253 protective coating Substances 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 230000005180 public health Effects 0.000 description 1
• 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 1
• 125000001453 quaternary ammonium group Chemical group 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 239000013049 sediment Substances 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 201000010153 skin papilloma Diseases 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
• 239000012312 sodium hydride Substances 0.000 description 1
• 229910000104 sodium hydride Inorganic materials 0.000 description 1
• 229910052938 sodium sulfate Inorganic materials 0.000 description 1
• 235000011152 sodium sulphate Nutrition 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 235000019337 sorbitan trioleate Nutrition 0.000 description 1
• 229960000391 sorbitan trioleate Drugs 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000010356 sorbitol Nutrition 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 229940124530 sulfonamide Drugs 0.000 description 1
• 150000003456 sulfonamides Chemical class 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 229950009390 symclosene Drugs 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 229940061367 tamiflu Drugs 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• RIFXIGDBUBXKEI-UHFFFAOYSA-N tert-butyl 3-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(=O)C1 RIFXIGDBUBXKEI-UHFFFAOYSA-N 0.000 description 1
• VVDCRJGWILREQH-UHFFFAOYSA-N tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC(B2OC(C)(C)C(C)(C)O2)=C1 VVDCRJGWILREQH-UHFFFAOYSA-N 0.000 description 1
• XMNLCEFSDGXDLL-UHFFFAOYSA-N tert-butyl 4-[2-[benzyl(hydroxy)carbamoyl]pyridin-4-yl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=NC(C(=O)N(O)CC=2C=CC=CC=2)=C1 XMNLCEFSDGXDLL-UHFFFAOYSA-N 0.000 description 1
• JQXAFXVMNBAQIT-UHFFFAOYSA-N tert-butyl 4-[2-[benzyl(hydroxy)carbamoyl]pyridin-4-yl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1C1=CC=NC(C(=O)N(O)CC=2C=CC=CC=2)=C1 JQXAFXVMNBAQIT-UHFFFAOYSA-N 0.000 description 1
• ZHXRGALVSBYWLF-UHFFFAOYSA-N tert-butyl 4-[2-[benzyl(oxan-2-yloxy)carbamoyl]pyridin-4-yl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1C1=CC=NC(C(=O)N(CC=2C=CC=CC=2)OC2OCCCC2)=C1 ZHXRGALVSBYWLF-UHFFFAOYSA-N 0.000 description 1
• KEEIJBAOTMNSEN-UHFFFAOYSA-N tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC=C1B1OC(C)(C)C(C)(C)O1 KEEIJBAOTMNSEN-UHFFFAOYSA-N 0.000 description 1
• ZRKPIWQNLHUKOY-UHFFFAOYSA-N tert-butyl 5-(trifluoromethylsulfonyloxy)-3,4-dihydro-2h-pyridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(OS(=O)(=O)C(F)(F)F)=C1 ZRKPIWQNLHUKOY-UHFFFAOYSA-N 0.000 description 1
• JWIOZKDQPDVJNT-UHFFFAOYSA-N tert-butyl 5-(trifluoromethylsulfonyloxy)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC=C(OS(=O)(=O)C(F)(F)F)C1 JWIOZKDQPDVJNT-UHFFFAOYSA-N 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• RVPPGOPRMQLGNS-UHFFFAOYSA-N tert-butyl n-(4-oxo-6-phenyl-3h-thieno[2,3-d]pyrimidin-2-yl)carbamate Chemical compound C=1C=2C(=O)NC(NC(=O)OC(C)(C)C)=NC=2SC=1C1=CC=CC=C1 RVPPGOPRMQLGNS-UHFFFAOYSA-N 0.000 description 1
• CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 1
• CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229960004906 thiomersal Drugs 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 125000002480 thymidyl group Chemical group 0.000 description 1
• KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 238000001665 trituration Methods 0.000 description 1
• ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
• 229940070710 valerate Drugs 0.000 description 1
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 230000017613 viral reproduction Effects 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 239000000230 xanthan gum Substances 0.000 description 1
• 229920001285 xanthan gum Polymers 0.000 description 1
• 235000010493 xanthan gum Nutrition 0.000 description 1
• 229940082509 xanthan gum Drugs 0.000 description 1
• XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1